abdullah's picture
Add files using upload-large-folder tool
b4e65c0 verified
raw
history blame
60.3 kB
1
00:00:20,840 --> 00:00:28,260
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ูŠูˆู… ุฅู† ุดุงุก ุงู„ู„ู‡ ู‡ู†ูƒู…ู„ ููŠ
2
00:00:28,260 --> 00:00:32,520
ุงู„ู€ hereditary bleeding disorders ูˆ ู‡ู†ุญูƒูŠ ููŠ ุงู„ู€ von
3
00:00:32,520 --> 00:00:37,520
Willebrand disease ูˆ ู‡ู†ุชุทุฑู‚ ู„ู„ู€ von Willebrand disease ู…ู† ุนุฏุฉ
4
00:00:37,520 --> 00:00:42,200
ุฒูˆุงูŠุง ุจุฏุงูŠุฉ ู‡ู†ู…ุณูƒ ุงู„ู€ factor ูˆ ู‡ูˆ von Willebrand factor
5
00:00:42,200 --> 00:00:46,340
ู…ู† ู†ุงุญูŠุฉ ุงู„ู€ structure ูˆ location ูˆ function ุซู…
6
00:00:46,340 --> 00:00:47,880
ู‡ู†ู…ุณูƒ ุงู„ู€ disease
7
00:00:53,480 --> 00:00:59,380
and diagnosis ูˆ treatment ุจุฏุงูŠุฉ
8
00:00:59,380 --> 00:01:04,320
von Willebrand disease ู‡ูˆ ุนุจุงุฑุฉ ุนู† ู…ุฑุถ ูŠุนุชุจุฑ family
9
00:01:04,320 --> 00:01:08,260
bleeding disorders ูˆู…ู† ุงุณู…ู‡ von Willebrand disease
10
00:01:08,260 --> 00:01:12,360
ุจูŠุนู†ูŠ ุฃู† von Willebrand factor ุฃู…ุง absent ุฃูˆ
11
00:01:12,360 --> 00:01:17,860
dysfunctional ุฃู…ุง absent ุฃูˆ dysfunctional ุจุฑูˆุชูŠู†
12
00:01:17,860 --> 00:01:26,770
ุฒูŠ ุฃูŠ ุจุฑูˆุชูŠู† ูŠุตู†ุน ููŠ ุงู„ุฌุณู… ู…ู† ุฎู„ุงู„ ุงู„ู€ gene ุงู„ู€ gene
13
00:01:26,770 --> 00:01:33,870
ุชุจุนู‡ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุดูุฑุฉ ุฌูŠู†ูŠุฉ ูˆููŠ ูƒุฑูˆู…ูˆุฒูˆู… 12 ูˆ ุจูŠุตูŠุฑ ู„ู‡
14
00:01:33,870 --> 00:01:37,730
expression ู„ู‡ุฐุง ุงู„ู€ gene ููŠ ู…ูƒุงู†ูŠู† ุงู„ู€ endothelial
15
00:01:37,730 --> 00:01:40,450
cells of ุงู„ู€ megakaryocyte ูˆ ุงุญู†ุง ุนุงุฑููŠู† ุฃู† ุงู„ู€
16
00:01:40,450 --> 00:01:44,830
endothelial cells ุจุชุตู†ุน ุจุนุถ ุงู„ู€ coagulation factors ูˆ ุชุชุฎุฒู†
17
00:01:45,280 --> 00:01:51,880
ุซู… ุงู„ู€ megakaryocytes ุจุฑุถู‡ ุจุชุตู†ุน ุงู„ู„ูŠ ู‡ูˆ ุฅูŠุด ุงู„ู€
18
00:01:51,880 --> 00:01:57,020
von Willebrand factor ุจูŠุตู†ุน ุงู„ู€ factor as
19
00:01:57,020 --> 00:02:02,200
preliminary structures ุซู… ุจูŠุชุทูˆุฑ ุฅู„ู‰ modified
20
00:02:02,200 --> 00:02:07,440
structures ู…ู† ุฎู„ุงู„ ุนู…ู„ูŠุงุช ูƒูŠู…ูŠุงุฆูŠุฉ ุชุชุถู…ู† ุจู„ู…ุฑุฉ
21
00:02:08,210 --> 00:02:11,830
ุจูŠุชุญูˆู„ ููŠู‡ุง ุงู„ู€ molecule ู…ู† Monomer ุฅู„ู‰ Polymer
22
00:02:11,830 --> 00:02:16,890
ูˆMonomer ูˆDimer ูˆTrimer ูˆPolymer ูˆุจุงู„ุชุงู„ูŠ ุจู†ุดูˆู
23
00:02:16,890 --> 00:02:21,550
ุนุฏุฉ ุฃุดูƒุงู„ ู…ู† ู…ูŠู†ุŸ ู…ู† ุงู„ู€ Multimer ุฃูˆ ู…ู† ุงู„ู€ Homo
24
00:02:21,550 --> 00:02:26,370
-dimeric ูŠุชุตุฏู‚
25
00:02:26,370 --> 00:02:33,110
ููŠ ุงู„ู†ู‡ุงูŠุฉ ุงู„ู€ molecule ูˆุนู„ู‰ ุณุทุญู‡ ุฃูˆ ูŠุญุชูˆูŠ ุนู„ู‰ ู…ูˆุงู‚ุน
26
00:02:33,110 --> 00:02:40,670
ุฑุงุจุทุฉ ู…ู†ู‡ุง ุงุฑุชุจุงุทู‡ ู…ูˆู‚ุน ุงุฑุชุจุงุทู‡ ุจุงู„ู€ factor 8 ุซู… two
27
00:02:40,670 --> 00:02:43,350
receptors ุจูŠุฑุชุจุทูˆุง
28
00:02:49,070 --> 00:02:54,310
ุซู… one receptor ุนู„ู‰ ุณุทุญ ุงู„ู€ collagen ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€
29
00:02:54,310 --> 00:03:00,170
sub-endothelial layer ูุจูƒูˆู†
30
00:03:00,170 --> 00:03:04,910
ุนู„ู‰ ุณุทุญู‡ binding sites ู…ู‡ู…ุฉ ุชุชุถู…ู† ู‡ุฐู‡ ุงู„ู€ binding
31
00:03:04,910 --> 00:03:05,270
sites
32
00:03:09,350 --> 00:03:11,990
ู‡ู†ุง ุฃู† ุงู„ู€ production of von Willebrand factor
33
00:03:11,990 --> 00:03:15,790
ูŠุชู… ููŠ ุงู„ู€ endothelium ุงู„ุณุจุจ ููŠ ุงู„ู€ megakaryocytes ูˆ
34
00:03:15,790 --> 00:03:21,350
most of the factor is usually synthesized in a
35
00:03:21,350 --> 00:03:27,010
secreted form ุจู…ุนู†ู‰ ุฃู† ู‡ูˆ free ููŠ ุงู„ุจู„ุงุฒู…ุง and
36
00:03:27,010 --> 00:03:34,210
stored in endothelium ููŠ ุงู„ู€ Weibel-Palade bodies ูˆููŠ
37
00:03:34,210 --> 00:03:38,270
ุงู„ู€ Alpha Granules of Platelets ูŠุจู‚ู‰ ู…ูˆุงู‚ุน ุชุฎุฒูŠู†ู‡
38
00:03:38,270 --> 00:03:42,230
ุนุงุฑููŠู†ู‡ุง ู‡ูŠ ุงู„ู€ Weibel-Palade bodies ูˆุงู„ู€ Alpha
39
00:03:42,230 --> 00:03:46,130
Granules of Platelets ูˆู…ูˆุงู‚ุน ุฅู†ุชุงุฌู‡ ู‡ูŠ ุงู„ู€
40
00:03:46,130 --> 00:03:52,290
Endothelial Cells ูˆ Megakaryocyte ุจูŠุณุชู„ุฒู…
41
00:03:52,290 --> 00:03:59,350
ุฎุฑูˆุฌ ุงู„ู€ von Willebrand ู…ู† ู…ุฎุงุฒู†ู‡ Inducer ูŠุณุชู„ุฒู…
42
00:03:59,350 --> 00:04:04,260
ู…ุฎุฑุฌ ุฃูˆ ุฎุฑูˆุฌ ุงู„ู€ von Willebrand factor ู…ู† ู…ุฎุงุฒู†ู‡
43
00:04:04,260 --> 00:04:12,540
certain inducer ุทุจุนุง ุฃูˆู„ุง ุจู€ stimulus ูุฅุฐุง
44
00:04:12,540 --> 00:04:16,480
ุจุฏู†ุง ู†ุทู„ุนู‡ ู…ู† ุงู„ู€ endothelial cells mostly ุงู„ู€
45
00:04:16,480 --> 00:04:20,120
stimulus ุงู„ู„ูŠ ุจูŠุณุชุฎุฏู… ู‡ูˆ ุงู„ู€ thrombin ูˆ ุงู„ู‡ูŠุณุชุงู…ูŠู† ูˆ
46
00:04:20,120 --> 00:04:25,540
ุงู„ู€ fibrin ูˆ ุงู„ู€ complement ู…ู† ุงู„ู€ C5 ู„ู€ C9 ุงู„ู„ูŠ ู‡ู…
47
00:04:25,540 --> 00:04:30,930
ุจูŠุณู…ูˆู†ู‡ membrane attack complex ูˆุฅุฐุง ูƒุงู† ุจุฏู†ุง
48
00:04:30,930 --> 00:04:36,190
ู†ุทู„ุนู‡ ู…ู† ุงู„ู€ platelet ู†ุณุชุฎุฏู… ุซุฑูˆู…ุจูŠู† ูˆ ADP ูˆูƒูˆู„ุงุฌูŠู†
49
00:04:36,190 --> 00:04:40,330
ุทุจุนุง
50
00:04:40,330 --> 00:04:44,270
ุงู„ู€ adhesion ูƒู„ู†ุง ุนุงุฑููŠู† ููŠ ุงู„ู€ von Willebrand ุญูƒูŠู†ุง
51
00:04:44,270 --> 00:04:48,230
ููŠู‡ุง ุฃูƒุชุฑ ู…ู† ู…ุฑุฉ ูˆู‚ู„ู†ุง ุจูŠู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ it has a
52
00:04:48,230 --> 00:04:51,550
dual role ุจูŠู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ ุงู„ู€ primary hemostasis
53
00:04:51,550 --> 00:04:54,930
ูˆููŠ ุงู„ู€ secondary hemostasis ููŠ ุงู„ู€ primary ุจูŠุนู…ู„
54
00:04:54,930 --> 00:05:00,110
adhesion ูˆ aggregation ูˆููŠ ุงู„ู€ secondary
55
00:05:00,110 --> 00:05:09,050
hemostasis ุจูŠุนู…ู„ 100% ุจุณ ุงู„ู€ factor .. ุขู‡ ุฃู†ุง ููŠ ุงู„ู€
56
00:05:09,050 --> 00:05:13,990
primary ู…ุงุดูŠ aggregation primary ู…ุง ููŠู‡ูˆุด ุจู‚ู‰ ู‡ูˆ
57
00:05:13,990 --> 00:05:17,030
ุงู„ู„ูŠ ุฏูˆุฑ ููŠ ุงู„ู€ primary ูˆุงู„ู„ูŠ ุฏูˆุฑ ููŠู‡ ู…ุง ููŠุด ููŠ ุงู„ู€
58
00:05:17,030 --> 00:05:20,310
secondary ูˆุนุงุฑููŠู† ุงู„ู€ function ุฃูˆ ุงู„ู€ mechanism of
59
00:05:20,310 --> 00:05:23,250
adhesion ูˆ ุงู„ู€ mechanism
60
00:05:26,970 --> 00:05:31,870
ู‡ูˆ ุงู„ู€ factor ุซู…ุงู†ูŠุฉ ุจูŠู‚ุนุฏ ู…ุน von Willebrand ุจูŠู‚ุนุฏ factor
61
00:05:31,870 --> 00:05:37,970
ุซู…ุงู†ูŠุฉ ุทูŠุจ ู†ูŠุฌูŠ ู„ู„ู…ุฑุถ ู†ูŠุฌูŠ ู„ุฅูŠุด ู„ู„ู…ุฑุถ ูˆุงู„ู€ von
62
00:05:37,970 --> 00:05:43,130
Willebrand disease ุฃูˆู„ ู…ู† ุญูƒู‰ ููŠู‡ ู‡ูˆ Eric von Willebrand
63
00:05:43,130 --> 00:05:47,530
ููŠ 1930 ูˆุณู…ู‰
64
00:05:47,530 --> 00:05:52,410
ููŠู‡ ุญูŠู†ู‡ hereditary pseudohemophilia hereditary
65
00:05:52,410 --> 00:05:58,230
pseudohemophilia ูˆูƒุงู†ุช ุงู„ุชุณู…ูŠุฉ ู†ุงุชุฌุฉ ุนู† ุงู„ุฃุณุจุงุจ
66
00:05:58,230 --> 00:06:02,490
ุงู„ุขุชูŠุฉ ุฃู†ู‡ ุฃูˆู„ finding ู„ู‚ู‰ ููŠู‡ prolongation
67
00:06:02,490 --> 00:06:05,970
ููŠ ุงู„ู€ bleeding time ู…ุงุดูŠ ู„ูƒู† ุงู„ู€ platelet count
68
00:06:05,970 --> 00:06:12,110
normal ุงู„ู€ platelet count normal ู…ุด ุฑุงูƒุจุฉ ุตุญ ูู„ู…ุฑุฉ
69
00:06:12,110 --> 00:06:18,270
ุงุชู†ูŠู† ู„ู‚ู‰ ููŠู‡ mucosal bleeding ู†ุจู‚ู‰ ุชู„ุงุชุฉ ู„ู‚ู‰ ุฃู†
70
00:06:18,270 --> 00:06:21,250
ุงู„ู…ุฑุถ ุจูŠุตูŠุจ ุงู„ุฌู†ุณูŠู†ุŒ male ูˆ femaleุŒ both sexes are
71
00:06:21,250 --> 00:06:26,250
affected ููŠ ุงู„ู€ hemophiliaุŒ ู†ุนุฑู ุฃู† ุงู„ู€ male ู‡ูˆ ุงู„ู€
72
00:06:26,250 --> 00:06:31,110
affected ูˆ ุงู„ู€ female ู‡ูŠ carrierุŒ ูˆุจุงู„ุชุงู„ูŠ ู‡ุฐุง ู„ุง ู‡ูˆ
73
00:06:31,110 --> 00:06:36,550
hemophilia ูˆู„ุง ู‡ูˆ ุฃูŠ bleeding disorder ุนุงุฏูŠ ุชุฃุซุฑุช
74
00:06:36,550 --> 00:06:40,740
ู…ู† ุฎู„ุงู„ ุงู„ู€ treatment ุทูŠุจุŒ ุดูˆ ุงู„ู„ูŠ ุตุงุฑุŸ ู‚ุงู„ูˆุง ููŠ
75
00:06:40,740 --> 00:06:44,780
1950ุŒ ุทุจุนุง ู‡ุฐุง ุงู„ูƒู„ุงู… ุชุทูˆุฑุช more investigationsุŒ ูููŠ
76
00:06:44,780 --> 00:06:51,160
1950 later on ุงูƒุชุดููˆุง ุฃู†ู‘ู‡ is associated with factor
77
00:06:51,160 --> 00:06:56,780
8 deficiencyุŒ ู…ุงุดูŠุŸ ุทุจุนุง ููŠ ุงู„ู€ von Willebrand ู‡ุฐุง
78
00:06:56,780 --> 00:07:00,480
ุงู„ูƒู„ุงู… ู…ูˆุฌูˆุฏุŸ ุขู‡ ู…ูˆุฌูˆุฏุŒ ู‚ุงู„ูˆุง factor 8 ูŠุจู‚ู‰ ู‚ู„ู‘ ..
79
00:07:00,480 --> 00:07:05,390
100% ูŠุจู‚ู‰ ู‚ู„ ุฅุฐุง ูƒุงู† ููŠุด von Willebrandู†ู…ุฑุฉ ููŠ ุงู„ู€
80
00:07:05,390 --> 00:07:10,890
1977 ุงูƒุชุดููˆุง ุงู„ู€ von Willebrand factor ููŠ ุงู„ู€ 80s
81
00:07:10,890 --> 00:07:20,570
ุนู…ู„ูˆุง gene cloning ู„ู„ู€ von Willebrand factor ุงู„ู€
82
00:07:20,570 --> 00:07:25,150
incidence ูˆ ุงู„ู€ frequency ูƒุงู†ูˆุง ู†ุณุจุชู‡ ุจุดูƒู„ ุนุงู… ู‡ูŠ 1
83
00:07:25,150 --> 00:07:31,710
% ู…ู† ุงู„ู€ population 1% ู…ู† ุงู„ู€ population ู„ูƒู† ุงู„ู…ุฑุถู‰
84
00:07:31,710 --> 00:07:39,190
ุจู€ ..ูŠุนู†ูŠ they manifest different or variable
85
00:07:39,190 --> 00:07:45,450
degrees of symptoms ุจู†ู„ุงู‚ูŠ ููŠ ู…ุฑุถู‰ ูƒุชูŠุฑ ุจุชุนุงู†ูŠุด ู…ู†
86
00:07:45,450 --> 00:07:50,590
ุฅุดูŠ ูˆ ู…ุฑุถู‰ ูƒุชูŠุฑ ุจุชุนุงู†ูŠ ู…ุงุดูŠ ูููŠ variation ููŠู‡ ููŠ
87
00:07:50,590 --> 00:07:56,450
ุงู„ู€ symptoms between patients between ู…ุฑุถู‰ ู„ุฃู† ู‡ูˆ
88
00:07:56,450 --> 00:08:01,950
patient ูˆุจุงู„ุชุงู„ูŠ ู‡ุฐุง ูŠุนู†ูŠ ุฃู† ุงู„ู…ุฑุถ ุจูŠุญู…ู„ ุฃูƒุชุฑ ู…ู†
89
00:08:01,950 --> 00:08:06,030
ู†ูˆุนู‡ ู…ุงุดูŠุŸ ู…ุงุฏุงู… ููŠ variation ููŠ ู†ูุณ ููŠ ุงู„ู€
90
00:08:06,030 --> 00:08:09,370
symptoms ู„ู†ูุณ ุงู„ู…ุฑุถ ูŠุจู‚ู‰ ููŠู‡ ุฃูƒุชุฑ ู…ู† ุฅูŠุด ู…ู†
91
00:08:09,370 --> 00:08:12,970
type ู…ู† ู‡ุฐุง ุงู„ู…ุฑุถ ูŠุนู†ูŠ ุงู„ู€ clinically significant
92
00:08:12,970 --> 00:08:18,030
form of von Willebrand disease ู†ุณุจุฉ ุงู„ุฅุตุงุจุฉ ููŠู‡ 125 ุดุฎุต ููŠ
93
00:08:18,030 --> 00:08:25,380
ุงู„ู…ู„ูŠูˆู† ููŠ ูƒู„ ู…ู„ูŠูˆู† ูˆุงู„ู€ severe ู†ุต ุฅู„ู‰ ุฎู…ุณุฉ ููŠ
94
00:08:25,380 --> 00:08:33,080
ุงู„ู…ูŠุฉ ู…ู† ู„ูƒู„ ู…ู„ูŠูˆู† ู…ุตุงุจูŠู† ุทุจุนุง ุจู‚ุชู„ ุฒูˆู…ุฉ ุงู„ู€
95
00:08:33,080 --> 00:08:37,880
inheritance pattern ุจุชู„ุงู‚ูŠ ุงู„ู€ male ูˆ ุงู„ู€ female are
96
00:08:37,880 --> 00:08:42,420
affected equally ู…ุงุดูŠุŸ
97
00:08:44,440 --> 00:08:48,280
ู„ุฃู† ุฅุฌูˆุง ูŠุนู…ู„ูˆุง classification ู„ู„ู…ุฑุถ ูˆุฌุงู„ูˆุง ุงู„ู€
98
00:08:48,280 --> 00:08:51,980
classification ุงู„ู„ูŠ ุจุฏู†ุงู‡ุง ุชุนุชู…ุฏ ุนู„ู‰ either the disease
99
00:08:51,980 --> 00:08:56,200
is quantitative or qualitative ู‡ู„ ู‡ูˆ quantitative
100
00:08:56,200 --> 00:09:05,380
ูˆู„ุง ุฅูŠุด ูˆู„ุง qualitative ุทุจุนุง ู‡ุฐุง ุจุดูƒู„ ุฃุณุงุณูŠ ูˆุทุจุนุง
101
00:09:05,380 --> 00:09:09,280
ูƒู„ู†ุง ุจู†ุนุฑู ุฏูˆุฑ von Willebrand factor ุจุงู„ู†ุณุจุฉ ุฅู„ู‰
102
00:09:09,280 --> 00:09:14,280
factor 8 ูˆุจุงู„ุชุงู„ูŠ ูƒู…ุงู† ุฃุฎุฏูˆุง ู‡ุฐุง ุงู„ูƒู„ุงู… ุจุนูŠู†
103
00:09:14,280 --> 00:09:19,800
ุงู„ุงุนุชุจุงุฑ ู…ู…ุง ุฃุฏู‰ ุฅู„ู‰ ุฃู†ู‡ ูŠุนู…ู„ูˆุง classification ู„ู„ู€
104
00:09:19,800 --> 00:09:25,420
disease ุฅู„ู‰ ุชู„ุช ุฃู†ูˆุงุน ุฃุณุงุณูŠุฉ ุชู„ุช ุฃู†ูˆุงุน ุฃุณุงุณูŠุฉ
105
00:09:25,420 --> 00:09:30,100
ูˆุจุจุณุงุทุฉ ุนุดุงู† ุชุญูุธูˆู‡ุง ุงู„ุดุจุงุจ ู‡ุฏุง ู‡ูŠ ุฃูƒุชุฑ ุญูุธูˆู‡ุง ูƒุฏู‡
106
00:09:30,100 --> 00:09:32,460
ู†ูˆุน ูˆุงุญุฏ ูˆุชู„ุงุชุฉ
107
00:09:35,960 --> 00:09:44,960
ู†ู…ุฑุง ูˆุงุญุฏ ูˆุชู„ุงุชุฉ are quantitative ู†ู…ุฑุง ุงุชู†ูŠู† is
108
00:09:44,960 --> 00:09:49,800
qualitative ู†ู…ุฑุง
109
00:09:49,800 --> 00:09:59,460
ูˆุงุญุฏ is mild to moderate and
110
00:09:59,460 --> 00:10:08,090
most common 70% ู…ู† ุงู„ู…ุฑุถู‰ ู…ู† type 1 ุจูŠู†ู…ุง type 3 is
111
00:10:08,090 --> 00:10:13,510
severe and
112
00:10:13,510 --> 00:10:17,330
rare
113
00:10:17,330 --> 00:10:23,050
ู„ุฃู†ู‡ ุจุดูƒู„ ุญูˆุงู„ูŠ 5% type
114
00:10:23,050 --> 00:10:31,530
2 ููŠ ู…ู†ู‡ ุฃู†ูˆุงุน ู…ุฎุชู„ูุฉ ุญุณุจ ุงู„ู€ mutation ูˆ ุจูŠุดูƒู„ ุฑุจุน
115
00:10:31,530 --> 00:10:37,030
ุงู„ุญุงู„ุงุช ุจูŠุดูƒู„ ุฑุจุน ุงู„ุญุงู„ุงุช ู„ุญูˆุงู„ูŠ ุฎู…ุณ ุฃู†ูˆุงุน ู…ุฎุชู„ูุฉ
116
00:10:37,030 --> 00:10:44,150
ู‡ุฐู‡ ุงู„ุชู‚ุณูŠู…ุฉ ุงู„ุฃุณุงุณูŠุฉ ู„ูƒู† ู‚ุงู„ูˆุง ุฃู†ู‘ู‡ ููŠ ุญุงุฌุฉ ุฌุฏูŠุฏุฉ
117
00:10:44,150 --> 00:10:48,170
ุงูƒุชุดููˆู‡ุง ุญูˆุงู„ูŠ 300 ุญุงู„ุฉ ุณุฌู„ุช ุญุงุฌุฉ ุจูŠุณู…ูˆู‡ุง
118
00:10:48,170 --> 00:10:54,430
Acquired von Willebrand factor ูˆ ุฅู† ุดุงุก ุงู„ู„ู‡ ู‡ู†ุญูƒูŠ
119
00:10:54,430 --> 00:10:58,590
ููŠู‡ ุจุงู„ุชูุตูŠู„ ูŠุนู†ูŠ ุงู„ู†ูˆุน ุงู„ุฑุงุจุน ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุฅูŠุด
120
00:10:59,200 --> 00:11:06,260
Acquired von Willebrand disease ุงู„ู€
121
00:11:06,260 --> 00:11:09,540
Clinical Manifestation ุดุจุงุจ ุฒูŠ ู…ุง ู‚ู„ุชู„ูƒูˆุง ุงู„ู€
122
00:11:09,540 --> 00:11:15,320
symptoms ุชุฎุชู„ู from mild and manageable symptoms
123
00:11:15,320 --> 00:11:19,100
ุฅู„ู‰ severe ูˆ unmanageable symptoms ุงู„ู€ symptoms
124
00:11:28,730 --> 00:11:34,550
ู‡ูŠ ู…ุฎุชู„ูุฉ ู…ู† ุงู„ู€ mild and manageable bleeding
125
00:11:34,550 --> 00:11:40,050
disorders ุฅู„ู‰ ุงู„ู€ very severe and unmanageable
126
00:11:40,050 --> 00:11:49,270
hemorrhage ูˆู…ู† ุงู„ุชุงู„ูŠ ุญุณุจ ู†ูˆุน ุงู„ู…ุฑุถ ุทุจุนุง ุทูŠุจ ุงุชู†ูŠู†
127
00:11:49,270 --> 00:11:54,730
ูˆ ุชู„ุงุชุฉ ุงู„ู€ bleeding episodes ููŠู‡ู… are life
128
00:11:54,730 --> 00:11:55,190
threatening
129
00:11:58,700 --> 00:12:02,820
ูƒู…ุงู† ุงู„ู€ .. ุงู„ู…ุฑุถ ู…ู…ูƒู† ุชุดูˆูู‡ ููŠ ุงู„ู€ .. ููŠ ุงู„ู€ female
130
00:12:02,820 --> 00:12:10,320
ุฃูƒุซุฑ ุถุฑูˆุฑุฉ ู„ุฅู† ุงู„ู€ female ุจุชุชุนุฑุถ ู„ู€ risk factor ุดู‡ุฑูŠ
131
00:12:10,320 --> 00:12:17,020
ุตุญุŸ ู‡ูˆ ุงู„ู€ bleeding ุฃูˆ ุงู„ู€ menorrhea ูƒู…ุงู†
132
00:12:17,020 --> 00:12:20,860
ุงู„ู€ bleeding ู…ู…ูƒู† ูŠุฒูŠุฏ ุฅุฐุง ูƒุงู† ุงู„ู…ุฑูŠุถ ุจูŠุงุฎุฏ aspirin
133
00:12:20,860 --> 00:12:24,320
ู„ุฅู†ู‡ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุจู†ุนุทู„ .. ุงุญู†ุง ุงู„ุจู„ุฏ ุงู„ู„ูŠ ุชู…ุนุทู„ุฉ
134
00:12:24,320 --> 00:12:33,230
ูˆ ..ุจู†ุฒูŠุฏ ุชุนุทูŠู„ู‡ุง ุฅู„ุง ุฃู†ู‡ู… ู…ู† ู…ุญุงุณู† ุงู„ุตุฏู ุฃู† ู‡ุฐุง
135
00:12:33,230 --> 00:12:38,270
ุงู„ู…ุฑุถ severity of symptoms are modified are
136
00:12:38,270 --> 00:12:44,710
decreased by age ูˆูŠุฌุงู„ูˆุง
137
00:12:44,710 --> 00:12:50,590
ุฃู†ู‡ ุจุชุจุฏุฃ ู…ุน ุงู„ุนู…ุฑ ุชุฒูŠุฏ ุชุฑูƒูŠุฒ ุงู„ู€ von Willebrand factor
138
00:12:50,590 --> 00:12:54,820
which is ู†ุนู…ุฉ ูˆูŠุนู†ูŠ ู‡ุฐู‡ ู†ุนู…ุฉ ู…ู† ู†ุนู… ุงู„ุฎุงู„ู‚ ุฃู† ู‡ุฐู‡
139
00:12:54,820 --> 00:12:58,560
ุงู„ู€ von Willebrand factor ุญุชู‰ ุนู†ุฏ ุงู„ู…ุฑุถู‰ ุชุจุฏุฃ ุชุฒูŠุฏ ุดูˆูŠุฉ
140
00:12:58,560 --> 00:13:06,540
ุดูˆูŠุฉ ูƒู„ ู…ุง ุงู„ุฅู†ุณุงู† ูƒุจุฑ ูƒู„ ู…ุง ุงู„ุฅู†ุณุงู† ูƒุจุฑ ูƒู…ุงู†
141
00:13:06,540 --> 00:13:11,880
ู‡ุฐู‡ ูƒู„ู‡ุง symptoms ู„ู„ู…ุฑุถ ููŠ ุญูˆุงู„ูŠ 60% ู…ู† ุงู„ู€
142
00:13:11,880 --> 00:13:16,760
symptoms ุจูŠุนุงู†ูŠ ู…ู†ู‡ุง ุงู„ู…ุฑูŠุถ ุงู„ู€ prolonged aPTT ูˆ
143
00:13:16,760 --> 00:13:27,800
40% easy bruising ูˆ hematoma 35% menorrhagia ู…ุงุดูŠ ูŠุนู†ูŠ
144
00:13:27,800 --> 00:13:36,680
ู‡ุฐู‡ ู‡ูŠ ุงู„ู€ symptoms ุฃุฎุฏุช ู†ุณุจ ู…ุฎุชู„ูุฉ ุนู†ุฏ ุงู„ู…ุฑุถู‰ ุงู„ู€
145
00:13:36,680 --> 00:13:40,660
GI bleeding ูˆ ุงู„ู€ dental extraction ูˆ ุงู„ู€ trauma ูˆ
146
00:13:40,660 --> 00:13:43,940
ุงู„ู€ postpartum ูˆ postoperative ุชุนุฑููˆุง ุงู„ู…ุตุทู„ุญุงุช ู‡ุฐู‡
147
00:13:43,940 --> 00:13:50,600
ูƒู„ู‡ุง ู…ุธุจูˆุท postpartum ู†ุฒูŠู ู…ุง ุจุนุฏ ุงู„ูˆู„ุงุฏุฉ
148
00:13:50,600 --> 00:13:53,100
postoperative
149
00:13:59,160 --> 00:14:05,820
ู…ุงุดูŠ ูŠุง ุดุจุงุจุŸ ุทูŠุจุŒ ุฎู„ู‘ูŠู†ูŠ ุฃุดูˆู ุงู„ุฃู†ูˆุงุน ุงู„ู…ุฎุชู„ูุฉ
150
00:14:05,820 --> 00:14:08,080
ู„ู„ู€ von Willebrand Disease ูˆุจู†ุจุฏุฃ ุจุงู„ู†ูˆุน ุงู„ุฃูˆู„
151
00:14:08,080 --> 00:14:13,360
ูˆู‡ูˆ ุงู„ู€ Type I ูˆุงุชูู‚ู†ุง ุนู„ู‰ ุฃู†ู‡ mild to moderate and
152
00:14:13,360 --> 00:14:21,460
it's a quantitative disorder ูˆุจุงู„ุชุงู„ูŠ
153
00:14:21,460 --> 00:14:23,100
ุงู„ู€ von Willebrand factor ุจู‚ู‰ ูุงูƒุชูˆุฑ could
154
00:14:23,100 --> 00:14:28,410
functioning normally ุนู†ุฏ ุงู„ู…ุฑุถู‰ ู‡ุฏูˆู„ usually
155
00:14:28,410 --> 00:14:35,230
inherited in autosomal dominant manner ูˆ
156
00:14:35,230 --> 00:14:40,370
ุงู„ุฅุตุงุจุฉ ููŠ ุงู„ุนุงุฆู„ุฉ ุงู„ูˆุงุญุฏุฉ ุงู„ูˆุงุญุฏุฉ ู‚ุฏ ุชุฎุชู„ู
157
00:14:40,370 --> 00:14:45,570
dramatically ูŠุนู†ูŠ
158
00:14:45,570 --> 00:14:51,910
ู…ู…ูƒู† ุชู„ุงู‚ูŠ ูˆุงุญุฏ ุฅุตุงุจุชู‡ ุฎููŠูุฉ ูˆ ุงู„ู€ symptoms ุนู†ุฏู‡
159
00:14:51,910 --> 00:14:57,970
ุฎููŠูุฉ ูˆ ุงู„ุชุงู†ูŠ ู…ู…ูƒู† ูŠูƒูˆู† ุงู„ู€ symptoms ุนู†ุฏู‡ู… ุนูŠุดุจู†ูุณ
160
00:14:57,970 --> 00:15:04,850
ุงู„ุนูŠู„ุฉ ูŠุนู†ูŠ type 2 ู‚ุณู…ูˆู‡ ุฅู„ู‰ ุฎู…ุณ ุฃู†ูˆุงุน ุญุณุจ ุงู„ู€
161
00:15:04,850 --> 00:15:12,030
mutation ูˆ ุชุฃุซูŠุฑู‡ุง ุนู„ู‰ ุงู„ู€ factor ุงู„ู€ von Willebrand
162
00:15:12,030 --> 00:15:20,010
equilibrium factor type 2 ู‚ุณู…ูˆู‡
163
00:15:20,010 --> 00:15:26,260
ุฅู„ู‰ ุฎู…ุณ ุฃู†ูˆุงุน ูˆ ุญุณุจ ุชุฃุซูŠุฑู‡ุง ุนู„ู‰ ุงู„ู€ factor ููŠู‚ุณู…ูˆู‡
164
00:15:26,260 --> 00:15:32,760
ุฅู„ู‰ type 2A ูˆ B ูˆ C ูˆ M ูˆ N ุฎู…ุณ ุฃู†ูˆุงุน ู…ุฎุชู„ูุฉ
165
00:15:32,760 --> 00:15:37,780
ู…ุนุธู…ู‡ุง ุจูŠุชุฃุซุฑ
166
00:15:37,780 --> 00:15:43,840
ุจูŠุฎุชู„ู ููŠู‡ุง ุตูุงุช ุงู„ู€ multimers formed from one to
167
00:15:43,840 --> 00:15:49,680
one ูŠุนู†ูŠ ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ููŠ type 2A ุจู†ู„ุงู‚ูŠ ููŠู‡ ู†ู‚ุต
168
00:15:49,680 --> 00:15:53,500
ููŠ ุงู„ู€ high and intermediate multimers ุฅูŠุด ุงู„ู€
169
00:15:53,500 --> 00:15:57,800
multimers ุฏู‡ ูŠุง ุดุจุงุจุŸ ู…ุด ู‚ูˆู„ู†ุง ุงู„ู€ von Willebrand factor
170
00:15:57,800 --> 00:16:06,440
ู„ู…ุง ุจุชุตู†ุน ุจูŠุงุฎุฏ ุนุฏุฉ ุฃุดูƒุงู„ ู…ุงุดูŠ ุจูŠุจุฏุฃ ุจุชุตู†ุน
171
00:16:06,440 --> 00:16:10,000
ุจู€ .. ุจู€ .. ุจู€ .. ุจู€ .. preliminary structure ุซู…
172
00:16:10,000 --> 00:16:15,240
ุจูŠุตู„ูˆุง modification ูุจู†ุดูˆู ุนุฏุฉ ุฃุดูƒุงู„ ู…ู† ู…ูŠู† ู…ู† ุงู„ู€
173
00:16:15,240 --> 00:16:18,300
von Willebrand factor ู…ู†ู‡ุง ุงู„ู€ monomer ูˆ ู…ู†ู‡ุง
174
00:16:18,300 --> 00:16:21,880
ุงู„ู€ dimer ูˆ ู…ู†ู‡ุง ุงู„ู€ trimer ู…ุงุดูŠ ูˆ ู…ู†ู‡ุง ุงู„ู€
175
00:16:21,880 --> 00:16:27,300
multimers multi ูŠุนู†ูŠ ุงูŠู‡ุŸ ุนุฏุฉ ู…ูŠุฉ ููŠู† ุงู„ู†ูˆุน ู‡ุฐุงุŒ
176
00:16:27,300 --> 00:16:30,560
ุจู†ู„ุงู‚ูŠ ู†ูˆุน ุงู„ู€ Multimers ุบุงูŠุจุŒ ู†ูˆุน ุฅูŠุด ุงู„ู€
177
00:16:30,560 --> 00:16:35,040
Multimers ุงู„ู€ High or Intermediate Multimers is
178
00:16:35,040 --> 00:16:43,120
absent ุงู„ู€ Type 2BุŒ ุงู„ู„ูŠ ู‡ูˆ ููŠู‡ ุนู†ุฏู‡ ุตูุฉ ู…ุฎุชู„ูุฉุŒ
179
00:16:43,120 --> 00:16:46,780
ุฃู†ู‡ ูˆุงู„ู„ู‡ ุงู„ู€ Multimers ุจุชุฑุชุจุท ููŠ ุงู„ู€ Platelet
180
00:16:46,780 --> 00:16:51,220
ExcessivelyุŒ ูŠุนู†ูŠ ุนู†ุฏู‡ุง High Affinity ู„ู…ูŠู†ุŸ
181
00:17:12,240 --> 00:17:19,220
Type IIc ุฑูŠุณุณู ูˆ ุงู„ู‡ูŠ ู…ุงู„ุชูŠู…ุงุฑ ููˆุฑู… is reduced ู„ูƒู†
182
00:17:19,220 --> 00:17:24,000
ุงู„ู€ multimers are qualitatively abnormal
183
00:17:27,060 --> 00:17:35,880
2M ุชู‚ู„ ู‚ุฏุฑุชู‡ ุนู„ู‰ ุงู„ุงุฑุชุจุงุท ุจู€ Factor 8 2M ุชู‚ู„ ู‚ุฏุฑุชู‡
184
00:17:35,880 --> 00:17:36,800
ุนู„ู‰ ุงู„ุงุฑุชุจุงุท ุจู€ Factor 8 2M ุชู‚ู„ ู‚ุฏุฑุชู‡ ุนู„ู‰ ุงู„ุงุฑุชุจุงุท
185
00:17:36,800 --> 00:17:36,820
2M ุชู‚ู„ ู‚ุฏุฑุชู‡ ุนู„ู‰ ุงู„ุงุฑุชุจุงุท ุจู€ Factor 8 2M ุชู‚ู„ ู‚ุฏุฑุชู‡
186
00:17:36,820 --> 00:17:36,940
ุนู„ู‰ ุงู„ุงุฑุชุจุงุท ุจู€ Factor 8 2M ุชู‚ู„ ู‚ุฏุฑุชู‡ ุนู„ู‰ ุงู„ุงุฑุชุจุงุท
187
00:17:36,940 --> 00:17:37,760
ุจู€ Factor 8 2M ุชู‚ู„ ู‚ุฏุฑุชู‡ ุนู„ู‰ ุงู„ุงุฑุชุจุงุท ุจู€ Factor 8
188
00:17:37,760 --> 00:17:42,200
2M ุชู‚ู„ ู‚ุฏุฑุชู‡ ุนู„ู‰ ุงู„ุงุฑุชุจุงุท ุจู€ Factor 8 2M ุชู‚ู„ ู‚ุฏุฑุชู‡
189
00:17:42,200 --> 00:17:44,400
ุนู„ู‰ ุงู„ุงุฑุชุจุงุท ุจู€ Factor 8 2M ุชู‚ู„ ู‚ุฏุฑุชู‡ ุนู„ู‰ ุงู„ุงุฑุชุจุงุท
190
00:17:44,400 --> 00:17:49,480
ุจู€ Factor
191
00:17:49,480 --> 00:17:56,430
8 2M ุชู‚ู‡ูˆ ุนุจุงุฑุฉ ุนู† severe ูˆุจุงู„ุชุงู„ูŠ ู…ุง ุฒุงู„ severe
192
00:17:56,430 --> 00:18:00,530
ูŠุนู†ูŠ ู…ู„ุงู‚ูŠุด factor ุงู„ู„ูŠ ู‡ูˆ von Willebrand factor ุนู„ุดุงู†
193
00:18:00,530 --> 00:18:07,210
ู‡ูŠูƒ ุงู„ู‚ูŠุงุณ ุจูŠูƒูˆู† undetectable Undetectable ูˆุบูŠุงุจ
194
00:18:07,210 --> 00:18:11,490
von Willebrand factor ุจูŠู†ุนูƒุณ ุณู„ุจุง ุนู„ู‰ ุงู„ู€ factor 8
195
00:18:11,490 --> 00:18:17,070
ูุจู†ู„ุงู‚ูŠ ุงู„ู…ุฑูŠุถ ู‡ุฐุง ุนู†ุฏู‡ hemophilia ุจุงู„ุงุถุงูุฉ ุฅู„ู‰
196
00:18:17,070 --> 00:18:23,660
von Willebrand disease ู…ุงุดูŠ ูŠุง ุดุจุงุจุŸ ู‡ุฐู‡ ุงู„ุชู„ุงุชุฉ ุฃู†ูˆุงุน
197
00:18:23,660 --> 00:18:27,440
ุงู„ู…ุฎุชู„ูุฉ ู‚ู„ู†ุง ููŠู‡ ู†ูˆุน ุฑุงุจุน ุณู…ูŠู†ุงู‡ Acquired von
198
00:18:27,440 --> 00:18:32,680
Willebrand Disease ูˆุฒูŠ ู…ุง ู‚ู„ุชู„ูƒูˆุง ุงูƒุชุดููˆู‡ ููŠ 1970
199
00:18:32,680 --> 00:18:38,520
ูˆุณุฌู„ุช ุญูˆุงู„ูŠ 300 ุญุงู„ุฉ ู…ู†ู‡ ูˆุบุงู„ุจุง
200
00:18:38,520 --> 00:18:44,260
ุจู†ุดูˆูู‡ ููŠ ุงู„ูƒุจุงุฑ with
201
00:18:44,260 --> 00:18:46,760
no personal or family bleeding history
202
00:18:49,780 --> 00:18:56,320
ูˆู„ู…ู‘ุง ุจู†ุดุชุบู„ ุนู„ูŠู‡ ุจูŠุฌูŠ ุงู„ุดุฎุต ูˆ ุจู†ู„ุงู‚ูŠ ุชู‚ุฑูŠุจุง ุจูŠุดุจู‡
203
00:18:56,320 --> 00:19:04,040
type 2 of von Willebrand disease ูˆ ุฌุงู„ ุงู„ู€ mechanisms
204
00:19:04,040 --> 00:19:13,540
ุจูŠุชุถู…ู† ุฃูƒุซุฑ ู…ู†ู‡ุง ู…ู†ู‡ุง ู†ู…ุฑุง ูˆุงุญุฏ auto antibody
205
00:19:13,540 --> 00:19:19,560
formation ู„ู…ูŠู†ุŸ 100% ุนุงุฑููŠู† ุฅูŠุด ุงู„ู€ auto-antibodyุŸ
206
00:19:19,560 --> 00:19:23,580
ูุฌุฃุฉ ูˆ ุจุฏูˆู† ุณุจู‚ ุฅู†ุฐุงุฑ ุชุจุฏุฃ ุชุชูƒูˆู‘ู† antibody ู„ู„ู€
207
00:19:23,580 --> 00:19:28,300
von Willebrand factor.ู†ุจุฑุฉ ุงุชู†ูŠู†ุŒ ู…ูŠูƒุงู†ูŠุฒู… ุชุงู†ูŠ
208
00:19:28,300 --> 00:19:32,220
ูŠุคุฏูŠ ู„ู€ acquired formุŒ ุฃู† ูˆุงู„ู„ู‡ ุงู„ู€ certain
209
00:19:32,220 --> 00:19:36,560
von Willebrand multimers ุจูŠุฒูŠุฏ ุงุฑุชุจุงุทู‡ุง ุจู€ tumorุŒ
210
00:19:36,560 --> 00:19:43,460
ุจุฅูŠู‡ุŸ ุจุงู„ู€ tumor massesุŒ ูˆุจุงู„ุชุงู„ูŠ ูˆูƒุฃู†ู†ุง ุจู†ุนู…ู„
211
00:19:43,460 --> 00:19:47,710
selective removal ู„ู…ูŠู†ุŸ ู„ู„ู€ von Willebrand factor.ูˆู‡ูˆ
212
00:19:47,710 --> 00:19:53,350
ุจู‚ู‰ acquired deficiency of von Willebrand factor ุตุญุŸ
213
00:19:53,350 --> 00:19:57,150
ู„ู…ุง ุงู„ู€ von Willebrand factor ูŠุชุทุจู‚ ุจุงู„ู€ tumor cell or
214
00:19:57,150 --> 00:20:03,210
reactive cell ุจูŠุฌูŠู„ ู…ู† ุงู„ู„ูŠ ุจู„ุงุฒู… ูˆ ู„ุง ุจูŠุฌูŠู„ ..
215
00:20:03,210 --> 00:20:05,770
ุจูŠุฌูŠู„ ู…ู† ุงู„ู„ูŠ ุจู„ุงุฒู… ูˆุจุงู„ุชุงู„ูŠ ู‡ูˆ ูƒุฃู†ู‡ุง indirectly
216
00:20:05,770 --> 00:20:10,870
ุจู†ุนู…ู„ Increased proteolysis of von Willebrand factor
217
00:20:10,870 --> 00:20:16,050
ุจุจุฏุฃ ูŠุชูƒุณุฑ ุจุฒูŠุงุฏุฉ ุจุฑุถู‡ ู…ู† ุงู„ู…ูŠูƒุงู†ูŠุฒู…ุงุช ูˆ ..
218
00:20:17,410 --> 00:20:19,730
Defective synthesis and release of von
219
00:20:19,730 --> 00:20:23,110
Willebrand factors from cellular compartment ูˆุงู„ู„ู‡ ุจูŠุจุฏุฃ
220
00:20:23,110 --> 00:20:33,710
ูŠุชุตู†ุน ุชุตู†ูŠุน ุฎุงุทุฆ ุฃูˆ ู‚ู„ูŠู„ ููŠ ุงู„ุฎู„ุงูŠุง ุงู„ู…ุตู†ุนุฉ ู…ู† ู…ุง
221
00:20:33,710 --> 00:20:36,590
ูŠู…ูŠุฒ ุงู„ู€ acquired disease ูŠุง ุดุจุงุจ acquired
222
00:20:36,590 --> 00:20:39,590
von Willebrand disease ุฃู†ู‡ ู„ุฌูˆุก associated with
223
00:20:39,590 --> 00:20:42,810
certain with other diseases ุฒูŠ ุงู„ู€ myelodysplastic
224
00:20:42,810 --> 00:20:46,520
proliferative ูˆ ุงู„ู€ lymphoproliferative ูˆ ุงู„ู€
225
00:20:46,520 --> 00:20:54,920
cardiovascular disease ูˆ ู‡ูƒุฐุง ู…ูู‡ูˆู…
226
00:20:54,920 --> 00:21:00,140
ูŠุง ุดุจุงุจ ุทูŠุจ ูƒูŠู ู†ุดุฎุต ุงู„ู€ von Willebrand disease ุฌุงู„ูˆุง
227
00:21:00,140 --> 00:21:05,540
ุฃุฏูˆุงุช ุงู„ุชุดุฎูŠุต ู‡ูŠ ูุญุตุงุช ุงู„ู€ hemostasis ูˆู‡ูŠ ุงู„ู€ BT ูˆ
228
00:21:05,540 --> 00:21:13,640
ุงู„ู€ aPTT ูˆ ุงู„ู€ bleeding time ู…ุงุดูŠ ู†ุจุฏุฃ ุจุงู„ู€ BT ูˆ ุงู„ู€
229
00:21:13,640 --> 00:21:20,080
aPTT ุฃู†ุง ุงู†ุชุจู‡ ุนู„ูŠุง ููŠ ุงู„ุชุดุฎูŠุต ุงู†ุชุจู‡ ุนู„ูŠุง ุจูŠ ุชูŠ ูˆ ุจูŠ
230
00:21:20,080 --> 00:21:23,240
ุชูŠ ุชูŠ ุงู„ู€ BT ูˆ ุงู„ู€ aPTT ูƒู„ ูƒูˆุง ุฃุฎุฏุชูˆู‡ุง ููŠ
231
00:21:23,240 --> 00:21:28,800
ุงู„ู…ุนู…ู„ ุจูŠ ุชูŠ ุจูŠุดุฎุต ู…ูŠู†ุŸ Extrinsic pathway ูˆ ุงู„ู€ ุจูŠ
232
00:21:28,800 --> 00:21:34,920
ุชูŠ ุชูŠ Intrinsic pathway ู„ุฃ ุงู„ู€ BT ููŠ ุงู„ู€ von Willebrand
233
00:21:34,920 --> 00:21:40,040
factor ุจูŠูƒูˆู† normal ู„ูŠุดุŸ ู„ุฃู†ู‡ ุฅู†ุชุฑู†ุฒู‚
234
00:21:45,680 --> 00:21:48,740
ุฃูŠูˆุฉ ุจุงู„ุธุจุท ู‡ูˆ ุญุงู…ู„ ูุงูƒุชูˆุฑ 8 ูˆ ูุงูƒุชูˆุฑ 8
235
00:21:48,740 --> 00:21:51,940
ุงู„ู„ูŠ ู†ุญุชุงุฌู‡ ููŠ ุงู„ู€ intrinsic ูˆ ุจุงู„ุชุงู„ูŠ ุงู„ู€
236
00:21:51,940 --> 00:21:55,840
prolongation ุจูŠุตูŠุฑ ููŠ ุฅูŠุดุŸ ููŠ ุงู„ู€ aPTT ุจูŠู†ู…ุง ุงู„ู€ BT
237
00:21:55,840 --> 00:22:01,660
ุจูŠูƒูˆู† normal ุทุจุนุง ูŠุง ุดุจุงุจ ู…ู‡ู… ุฌุฏุง ุฃู† ููŠ ูƒุซูŠุฑ ู…ู†
238
00:22:01,660 --> 00:22:08,160
ุงู„ุฃุญูŠุงู† ุจูŠุทู„ุนู„ูƒ aPTT normal ุฃู† ุจุนุถ ุงู„ู…ุฑุถู‰ ู„ูƒู† ู‡ุฐุง
239
00:22:08,160 --> 00:22:15,160
ู„ุง ูŠุณุชุซู†ูŠ ุงู„ู€ von Willebrand disease ู„ูŠุดุŸ ู„ุฃู† ู‚ู„ู†ุง
240
00:22:15,160 --> 00:22:18,280
ุนู† ุจุนุถ ุงู„ุฃู…ุฑุงุถ ุงู„ู„ูŠ ุจูŠูƒูˆู† ุงู„ู€ factor ููŠู‡ุง normal
241
00:22:18,280 --> 00:22:24,500
ุชู‚ุฑูŠุจุง ุฒูŠ type I type I ุฅูŠุด ุชู‚ุฑูŠุจุง ู…ุง ุจูŠุนุงู†ูŠ
242
00:22:24,500 --> 00:22:27,200
ุงู„ู…ุฑูŠุถ ู…ู† ุฃูŠ ุญุงุฌุฉ ูˆ ุงู„ู€ von Willebrand factor
243
00:22:27,200 --> 00:22:31,420
functioning normally ูˆุจุงู„ุชุงู„ูŠ ู„ุง ูŠุณุชุซู†ูŠ ุชุดุฎูŠุต ู…ู†
244
00:22:31,420 --> 00:22:41,420
ุงู„ู€ von Willebrand factor ุทุจ ุงู„ู€ .. ููŠ ุจุนุถ ุงู„ุฃุญูŠุงู† both
245
00:22:41,420 --> 00:22:47,700
tests are prolonged ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ูŠุง ุดุจุงุจ ุฏู‡
246
00:22:47,700 --> 00:22:51,980
ุชุณุชู†ู‰ ุฃุณุจูˆุนูŠู† ุซู… ุชุนูŠุฏ ุงู„ูุญุต ู…ุฑุฉ ุซุงู†ูŠุฉ ุนู„ุดุงู† ุฅูŠุดุŸ
247
00:22:51,980 --> 00:22:57,060
ุนู„ุดุงู† ุชุชุญู‚ู‚ ู…ู† ู‡ุฐู‡ ุงู„ู†ุชูŠุฌุฉ ุฅุฐุง ูƒุงู† ุดุงูƒูƒ ููŠ ุงู„ู€
248
00:22:57,060 --> 00:23:05,540
disease ู…ุงุดูŠ ุฅุฐุง ูุญุตูŠู† ุทู„ุนุฉ prolonged ุฅุฐุง ุงู„ูุญุตูŠู†
249
00:23:05,540 --> 00:23:09,360
ุทู„ุนุฉ normal ู‚ู„ู†ุง ุงู„ู€ aPTT ุงู„ู€ normal ู„ุง ูŠุณุชุซู†ูŠ
250
00:23:09,360 --> 00:23:13,300
ุชุดุฎูŠุตูŠุง ุงู„ู€ von Willebrand ุฅุฐุง ุงู„ุชุงู†ูŠู† ุทู„ุนุฉ abnormal
251
00:23:13,300 --> 00:23:17,960
ุฏูุชุฑูŠุฏ ุงู„ูุญุต ุจุนุฏ ุดุจุนูŠู† ุฅุฐุง ูƒู†ุช ุดุงูƒู… ููŠ von Willebrand
252
00:23:17,960 --> 00:23:23,080
disease ู…ุงุดูŠุŸ ุงู„ุฃุตู„ ูŠุทู„ุน ุงู„ BT normal ูˆ ุงู„ PTT
253
00:23:23,080 --> 00:23:25,700
abnormal ู…ุงุดูŠุŸ
254
00:23:31,170 --> 00:23:34,630
ุทุจ ุฃู†ุง ู†ูุณูŠ ุทู„ุน ูŠุนู†ูŠ ู„ู„ุฅุซู†ูŠู† ูˆ ุจุฑู‡ ุงู„ video ุงู„ู„ูŠ
255
00:23:34,630 --> 00:23:38,230
.. ุฃู†ุช ุชู‚ุนุฏ ุงู„ูุญุต ุจู‚ุนุฏุด ู…ุนุงูŠุง ุจู‚ุนุฏุด ู…ุนุงูŠุง ุฒุงุฏ ุทุจุนุง
256
00:23:38,230 --> 00:23:43,870
ู„ุฃู† ุงู„ู…ุฑุถ ู…ุด ู…ู‡ู… ุจุงู„ุจุฑุงุฏุฑ ูˆ ุจุฏูƒ ุชุฏูˆุฑ ุนู„ู‰ ุญุงุฌุฉ
257
00:23:43,870 --> 00:23:50,270
ุซุงู†ูŠุฉ ู„ุฅู† ูˆุงุญุชู…ุงู„ูŠ ูƒุจูŠุฑ ุชูƒูˆู† ุฎู„ุทุงู† ููŠ ุงู„ุนูŠู†ุฉ ููŠ
258
00:23:50,270 --> 00:23:55,090
ุงู„ูุญุต ุงู„ุฃูˆู„ุงู†ูŠ ูˆ ุงุญู†ุง ุจู†ุนูŠุฏ ุนุดุงู† ู†ุชุญู‚ู‚ ู…ู† ุงู„ู†ุชูŠุฌุฉ
259
00:23:55,090 --> 00:23:56,630
ุจุงุณุชุฎุฏุงู… ุนูŠู†ุฉ
260
00:24:04,220 --> 00:24:07,720
ุจุงู„ู†ุณุจุฉ ู„ู„ bleeding time ูŠุง ุดุจุงุจ ู„ุบุงูŠุฉ ุงู„ุขู† ู…ุงุญุฏุด
261
00:24:07,720 --> 00:24:15,320
ุจูŠุทู„ุจูˆุง ู„ุฃู†ู‡ non specific ูˆ non sensitive not
262
00:24:15,320 --> 00:24:21,080
specific ูˆ not sensitive ูˆ the test by itself
263
00:24:21,080 --> 00:24:25,540
subject to varying wide variation ูŠุนู†ูŠ varying
264
00:24:25,540 --> 00:24:27,480
results
265
00:24:32,210 --> 00:24:37,710
ู…ุงุดูŠุŸ ู…ุง ู‡ูŠ ุงู„ู…ุดุงูƒู„ ุงู„ุชูŠ ุชูˆุงุฌู‡ู†ุง ููŠ ุชุดุฎูŠุต von
266
00:24:37,710 --> 00:24:42,390
Willebrand disease ุชุจู‚ู‰ ุนู„ู‰ ู‡ุฐู‡ ุงู„ู†ู‚ุงุท ุงู„ู…ู‡ู…ุฉ ู…ุดุงูƒู„
267
00:24:42,390 --> 00:24:46,990
ุงู„ุชูŠ ุชูˆุงุฌู‡ู†ุง ููŠ ุชุดุฎูŠุต ู…ูŠู† ุงู„ von Willebrand disease
268
00:24:46,990 --> 00:24:51,610
ู†ู…ุฑุฉ
269
00:24:51,610 --> 00:24:56,630
ูˆุงุญุฏ von Willebrand level itself ู‚ุงู„ูˆ it vary
270
00:24:56,630 --> 00:24:57,430
greatly
271
00:25:01,970 --> 00:25:05,650
ูˆุจุชุงุฎุฏ ุงู„ flash ู„ุฃู†ู‡ ุงุนุชุจุฑู‡ acute phase protein
272
00:25:05,650 --> 00:25:11,590
ุงูŠุด ุงู„ acute phase protein ูŠุง ุดุจุงุจุŸ acute phase
273
00:25:11,590 --> 00:25:15,830
protein ู‡ูˆ ุนุจุงุฑุฉ ุนู† protein ุจุชุดุชู…ุน ููŠ ุงู„ liver ููŠ
274
00:25:15,830 --> 00:25:20,610
ุธุฑูˆู ู…ุนูŠู†ุฉ ุจูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ู…ู† ู‡ุฐู‡ ุงู„ุธุฑูˆู
275
00:25:20,610 --> 00:25:24,730
psychological stresses ุฒูŠ ู…ุซู„ู‹ุง ุงู„ู„ูŠ ุฃุฎุฏุชู‡ ู…ุซู„ู‹ุง
276
00:25:24,730 --> 00:25:29,120
ููŠ ุงู„ hormone ููŠ ุงู„ endocrine ุฅู† ุงู„ูˆุงุญุฏ ู„ู…ุง ูŠูƒูˆู†
277
00:25:29,120 --> 00:25:32,000
ุฎุดุฑุง ุงู…ุชุญุงู† ูˆุฎุงูŠู ู…ู†ู‡ ูŠู‚ูˆู„ ุงู„ู„ูŠ ุญู‚ุง ุจูƒู…ูŠุงุช ูƒุจูŠุฑุฉ
278
00:25:32,000 --> 00:25:36,140
ูˆุธุจุท psychological factor ุจูŠุณู…ูˆู‡ุง adrenergic
279
00:25:36,140 --> 00:25:41,860
stimuli ุฃูˆ
280
00:25:41,860 --> 00:25:45,980
ู…ุซุงู„ ุขุฎุฑ ูƒู…ุงู† ุฃุฎุฏุชู‡ ุฃูƒูŠุฏ ููŠ ุงู„ูุญุตุงู† ุณู…ุนุชูˆุง ุจูุญุต
281
00:25:45,980 --> 00:25:51,640
CRPุŸ C-reactive protein ุณู…ุนุชูˆุง ููŠู‡ุŸ ุฃูŠ ุฃูƒูŠุฏ
282
00:25:51,640 --> 00:25:56,580
ุณู…ุนุชูˆุง ููŠู‡ ุฃุฎุฏุชู‡ ููŠ ุงู„ุณูˆุงู‚ู„ C-reactive protein ู‡ูˆ
283
00:25:56,580 --> 00:25:57,200
ุจุฑู‡ ุงู„ูุญุต
284
00:25:59,960 --> 00:26:06,940
ู…ุงุดูŠ ู‡ูˆ ุงู„ specific test ุงู„ู„ูŠ ุจู†ุนู…ู„ู‡ ููŠ ุญุงู„ุงุช ุงู„
285
00:26:06,940 --> 00:26:11,940
inflammation ุบูŠุฑ ุงู„ ESR ุงู„ ESR ุจู†ุนุชุจุฑู‡ุง non
286
00:26:11,940 --> 00:26:16,580
specific ู…ุดูŠ ู„ูŠู‡ุŸ ูŠุงู„ู‡ ู„ุฅู†ู‡ ููŠ ุงู„ inflammatory
287
00:26:16,580 --> 00:26:20,320
reaction C-reactive protein ู‡ูˆ ุจุฑุถู‡ ุงู„ protein
288
00:26:20,320 --> 00:26:23,820
is an acute phase ุจูŠุตู†ุน ุจุฌู†ูˆู†ูŠุงุช ูƒุจูŠุฑุฉ ุทูˆู„ ู…ุง ููŠ
289
00:26:23,820 --> 00:26:28,970
inflammation ูˆูŠูˆู… ู…ุง ูŠุฑูˆุญ ุงู„ inflammation ูŠุฑูˆุญ
290
00:26:28,970 --> 00:26:32,570
ุจุถุจุท ุงู„ู„ูŠ ุงู†ุชุฌ ูุฅุฐุง ูƒุงู† ููŠู‡ inflammation ู‡ูŠุฏูŠู†ุง
291
00:26:32,570 --> 00:26:35,690
positive ูˆุฅุฐุง ู…ููŠุด inflammation ู‡ูŠุฏูŠู†ุง negative
292
00:26:35,690 --> 00:26:42,390
ู…ุงุดูŠุŸ ุงู„ von Willebrand factor ู‡ูˆ ูˆุงุญุฏ ู…ู† ู‡ุฐู‡ ุงู„
293
00:26:42,390 --> 00:26:45,110
factors acute phase protein ูŠุตู†ุน ู…ู† ูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ุฅู†
294
00:26:45,110 --> 00:26:51,310
ููŠ ุธุฑูˆู ู…ุนูŠู†ุฉ ู…ุงุดูŠุŸ ู‡ูˆ ูˆ ุงู„ ferritin ูˆ C-reactive
295
00:26:51,310 --> 00:26:58,630
protein ูˆู…ุฌู…ูˆุนุฉ ู…ู† ุงูŠุดุŸ ู…ู† ุงู„ุจุฑูˆุชูŠู†ุงุช ุจุชุนุชุจุฑ C
296
00:26:58,630 --> 00:27:05,570
-reactive ุจุชุนุชุจุฑ acute physiological ูุจูŠุฎุชู„ู
297
00:27:05,570 --> 00:27:11,050
ุชุฑูƒูŠุฒู‡ุง ุจุงุฎุชู„ุงู ุงู„ูˆุถุน ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ููŠ ุงู„
298
00:27:11,050 --> 00:27:17,110
psychological .. physiological stresses ุฅู†ู‡ ุขู‡ ุชุญุช
299
00:27:17,110 --> 00:27:22,850
ุถุบุท ู†ูุณ ุงู„ุฅู†ุณุงู† ุฃูˆ ู…ุฑูŠุถ ุงุฌุงูƒ ุทูู„ ุตุบูŠุฑ ุงุฌุงูƒ ุจุนูŠุท
300
00:27:22,850 --> 00:27:28,640
ุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ูˆู‡ูˆ ุจุนูŠุท ุทูˆู„ ู…ุง ู‡ูˆ ุจุนูŠุท ู‡ูŠ ุงู„ู†ุณุจุฉ
301
00:27:28,640 --> 00:27:34,240
ุงุญุชู…ุงู„ูŠ ูƒุจูŠุฑ ุงู„ู†ุชูŠุฌุฉ ุชูƒูˆู† ุฎุงุทุฆุฉ ู„ุฃู†ู‡ ู‡ูŠุฎุชู„ูู‡ุงุด ุงู„
302
00:27:34,240 --> 00:27:39,520
crying ู‡ูˆ ุนุจุงุฑุฉ ุนู† physiological stress ู„ู„ุทูู„ ูˆุฅุฐุง
303
00:27:39,520 --> 00:27:43,100
ูƒุงู† ุตุงุฑ ููŠ physiological stress ูŠุนู†ูŠ ุตุงุฑ ููŠ ุฒูŠุงุฏุฉ
304
00:27:43,100 --> 00:27:46,640
ููŠู‡ุงุด ููŠ ุงู„ von Willebrand factor ูŠุนู†ูŠ ู„ูˆ ูƒุงู† ู…ุฑูŠุถ ุจุฏูŠู‡
305
00:27:46,640 --> 00:27:50,780
ูŠุทู„ุน normal ุตุญุŸ ู„ูˆ ูƒุงู† ู…ุฑูŠุถ ุจุฏูŠู‡ ูŠุทู„ุน ุนูŠุงุด normal
306
00:27:52,240 --> 00:27:55,340
ููŠ ู…ูˆุฌูˆุฏ ุงู„ุฅุณุชุฑูˆุฌูŠู† ูˆ ุงู„ vasopressin ูˆ ุงู„ growth
307
00:27:55,340 --> 00:28:00,620
hormone ูˆ ุงู„ adrenergic stimuli ูƒู„ู‡ู… ุจูŠุนู†ูŠ ุงู„
308
00:28:00,620 --> 00:28:06,700
adrenaline release ูƒู„ู‡ู… ุจูŠุคุฏูˆุง ุฅู„ู‰ ุฒูŠุงุฏุฉ ุงู„
309
00:28:06,700 --> 00:28:12,400
von Willebrand factor ู‡ูˆ ุจุงู„ุชุงู„ูŠ ุงู„ von Willebrand
310
00:28:12,400 --> 00:28:16,460
factor ู…ู…ูƒู† ูŠุทู„ุน normal ู…ุงุดูŠ
311
00:28:20,140 --> 00:28:25,700
ุดูˆ ู„ุงุฒู… ุฃุนู…ู„ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉุŸ ุงู„ุฃุตู„ ุฅู†ูŠ ุฃุนูŠุฏ ุงู„ูุญุต
312
00:28:25,700 --> 00:28:32,760
to confirm the results ูุจูŠู†ุตุญูˆุง ุฏุงุฆู…ุง ุจุฅู†ู‡ ู†ุนูŠุฏ
313
00:28:32,760 --> 00:28:38,360
ุงู„ูุญุต ุนุฏุฉ ู…ุฑุงุช in a two weeks interval ุจูŠู† ูƒู„ ูุญุต
314
00:28:38,360 --> 00:28:47,000
ูˆ ุงู„ุซุงู†ูŠ ุฃุณุจูˆุนูŠู† ู…ุงุดูŠ ุนุดุงู† ุงูŠู‡ุŸ ุนุดุงู† ุฃุตู„ ุฅู„ู‰ ุชุดุฎูŠุต
315
00:28:47,000 --> 00:28:48,340
ุตุญูŠุญ
316
00:28:50,550 --> 00:28:53,970
ุทุจุนุง ููŠ .. ูŠู†ุตุญ ุฃุซู†ุงุก ุฃุฎุฐ ุงู„ุนูŠู†ุฉ ุฃู† ุงู„ู…ุฑูŠุถ ูŠูƒูˆู†
317
00:28:53,970 --> 00:28:59,610
ุจุนูŠุฏ ุนู† ุฃูŠ stresses ู…ู† ุถู…ู†ู‡ุง ุฃูŠ hemorrhageุŒ ุฃูŠ
318
00:28:59,610 --> 00:29:05,290
ุงู„ู„ูŠ ู‡ูˆ infection ุฃูˆ extreme exerciseุŒ ูƒู„ ู‡ุฐู‡ ู…ู…ูƒู†
319
00:29:05,290 --> 00:29:10,390
ุชุนู…ู„ pregnancyุŒ ู„ุงุฒู… ุชูƒูˆู† ุจุนูŠุฏ ุนู† ุงูŠู‡ ู‡ุฐู‡ ุงู„ุดุบู„ุงุช
320
00:29:10,390 --> 00:29:16,010
ุนุดุงู† ุชุตู„ ุฅู„ู‰ ู†ุชูŠุฌุฉ ูƒุจูŠุฑุฉ ูŠุจู‚ู‰ ู‡ุฐู‡ ุงู„ู…ุดูƒู„ุฉ ุงู„ุซุงู†ูŠุฉ
321
00:29:16,010 --> 00:29:18,750
ุงู„ู„ูŠ ุจุชูˆุงุฌู‡ู†ุง ุงู„ู…ุดูƒู„ุฉ ุงู„ุซุงู„ุซุฉ ู‚ุงู„ูˆุง ุฅู† ููŠ ุจุนุถ
322
00:29:18,750 --> 00:29:24,430
ุงู„ู†ุงุณ ุจุชุชุฃุซุฑ ู†ุณุจุฉ ุงู„ factor ุญุณุจ ูุตูŠู„ุฉ ุงู„ุฏู… ูˆู‡ุฐู‡
323
00:29:24,430 --> 00:29:29,110
ุนุจุงุฑุฉ ุนู† statistical data ู…ุงุดูŠุŸ ู‚ุงู„ูˆุง ุญุณุจ ู†ูˆุน ุงู„ุฏู…
324
00:29:29,110 --> 00:29:38,030
ุจู†ู„ุงู‚ูŠ ุงู„ factor ูŠุนู†ูŠ ุจูŠุฎุชู„ู ู…ู† ุดุฎุต ุฅู„ู‰ ุขุฎุฑ ุทูŠุจ
325
00:29:38,030 --> 00:29:44,610
ูƒูŠู ู†ุดุฎุต ูŠุง ุดุจุงุจุŸ ูƒูŠู ู†ุดุฎุตุŸ ุดูˆููˆุง ู…ูŠู‡ุฑ ููŠ ุญูˆุตุงุชู†ุง
326
00:29:44,610 --> 00:29:48,030
ุงู„ู„ูŠ ุจู†ุนู…ู„ู‡ุง ู‚ุงู„ูˆุง ุจู†ุนู…ู„ ู†ู…ุฑุฉ ูˆุงุญุฏ ristocetin ู…ุน ุงู„
327
00:29:48,030 --> 00:29:51,470
platelets ุฃุดู‡ุฑ
328
00:29:51,470 --> 00:29:51,950
ristocetin ู…ุน ุงู„ platelets
329
00:30:00,930 --> 00:30:04,590
ููŠ aggregation ููŠ ุงูŠุด ุจูŠุฌูŠุณ ุงู„ aggregationุŸ ููŠ
330
00:30:04,590 --> 00:30:07,910
aggregometerุŒ ู…ุธุจูˆุทุŸ ุนุดุงู† ุฃู†ุง ุฃุฎุฏู†ุงู‡ุง ูƒู„ู‡ุŸ ุงู„ุฌู‡ุงุฒ
331
00:30:07,910 --> 00:30:13,130
ุงู„ aggregometerุŸ ุขู‡ ูƒู„ ุงู„ agonists ุฏูŠ ุทูŠุจ ุงูŠุด ุจูŠุนู…ู„
332
00:30:13,130 --> 00:30:15,630
ููŠ ุงู„ ristocetin systemุŸ ุฌุงู„ู‡ ristocetin systemุŒ ุฅุฐุง
333
00:30:15,630 --> 00:30:24,450
ููƒุฑูŠู†ุด ุจู‚ู‰ุŒ ูŠุณุชุทูŠุน ุฃู† ูŠู†ุดุท ุญุชู‰ ุงู„ุจู„ุงุชู„ูŠุช ุงู„ู…ุญููˆุธุฉ
334
00:30:24,450 --> 00:30:30,590
ููŠ ุงู„ formalin ู…ุฌุจูˆุทุŒ ูู‡ูˆ strong agonistุŒ strong
335
00:30:30,590 --> 00:30:36,770
agonistุŒ ู…ุงุดูŠุŸ ูุจู†ุดูˆู ุชุฃุซูŠุฑู‡ ุนู„ู‰ ุงู„ platelet
336
00:30:36,770 --> 00:30:43,810
functionุŒ ู…ุงุดูŠุŸ ููŠ ูˆุฌูˆุฏ ุงู„ูุฑู‚ ุงู„ู„ูŠ ุจู†ุฃุฎุฏู‡ุŒ ู…ุงุดูŠ
337
00:30:43,810 --> 00:30:49,860
ุจู†ุนู…ู„ุŒ ุจุฑูˆุญ ูˆ ุงุญู†ุง ุฌุงูŠุจูŠู† von Willebrand Factor
338
00:30:49,860 --> 00:30:53,560
ุฃูŠู‡ุง induce ุงู„ู€ von Willebrand Factor to bind
339
00:30:53,560 --> 00:30:59,780
with the platelet receptor ุจูŠุฑุชุจุท ููŠ ู…ูŠู†ุŸ GP1B
340
00:30:59,780 --> 00:31:04,820
ู…ุธุจูˆุท ุทุจ ุงูŠุด ุจุฏู‡ ูŠุนู…ู„ุŸ ุจุฏู‡ ูŠุนู…ู„ adhesionุŒ ู‡ุฐูŠ
341
00:31:04,820 --> 00:31:12,380
ุฌุงุจู„ูŠ ุงู„ aggregationุŒ ู…ุธุจูˆุทุŸ ุทูŠุจุŒ ุซู… ุจ .. ุงู„ุฑุณูˆ ..
342
00:31:12,380 --> 00:31:16,420
ุจุชู‚ูŠุณ ุงู„ุฑุณูˆ ููŠ certain cofactor activity ู…ู† ุฎู„ุงู„
343
00:31:17,540 --> 00:31:21,980
ุงู„ agglutination ุฃูˆ metabolically inactive
344
00:31:21,980 --> 00:31:32,160
platelet ุชุจุฏุฃ ุชุชุฑุณู„ ุซู…
345
00:31:32,160 --> 00:31:37,960
ุจุชุนู…ู„ ristocetin-induced platelet activation RIPA
346
00:31:37,960 --> 00:31:44,240
ุงุฎุชุตุงุฑ ู„ู…ูŠู†ุŸ ristocetin-induced
347
00:31:44,240 --> 00:31:46,420
platelet
348
00:31:55,420 --> 00:31:59,420
activation ุทุจุนุง ู‡ุฐุง ุนุจุงุฑุฉ ุนู† ุงูŠุด ุจุชู‚ูŠุณ ุงู„
349
00:31:59,420 --> 00:32:02,500
metabolically active platelet ุงู„ูƒู„ุงู… ู‡ุฐุง ูƒู„ู‡
350
00:32:02,500 --> 00:32:05,720
ุจุชู‚ูŠุณู‡ ุจูˆุงุณุทุฉ ุงู„ aggregometer which is used to
351
00:32:05,720 --> 00:32:08,440
measure the rate of aggregation
352
00:32:24,350 --> 00:32:30,570
ุฎู„ุตุชู‡ุŸ ู…ุงุดูŠุŸ ุทูŠุจ ุดุบู„ุฉ ุซุงู†ูŠุฉ immunological
353
00:32:30,570 --> 00:32:36,190
test ุจุชู‚ูŠุณ ุงู„ von Willebrand antigen ุนุดุงู† ุชู‚ูŠุณ von
354
00:32:36,190 --> 00:32:39,250
Willebrand antigen ุจุฏูƒ ุชุนู…ู„ู‡ antibody ูุจุชุตูŠุฑ ุงู„ุชูุงุนู„
355
00:32:39,250 --> 00:32:43,070
antigen-antibody reaction ุจุชู‚ูŠุณู‡ ูƒูŠูุŸ quantitatively
356
00:32:43,070 --> 00:32:48,120
ูŠุง ุดุจุงุจ ุจุงู„ ELISA Technique ู…ุด ุฃุฎุฏุชูˆู‡ุง ุฏู‡ ุงู„ ELISAุŸ
357
00:32:48,120 --> 00:32:53,320
100% ุจุชุนุชุจุฑู‡ ุจุฑูˆุชูŠู†ุŒ ุจุชูƒูˆู† ู„ู‡ antibody ูˆ cast by
358
00:32:53,320 --> 00:33:02,100
ELISA quantitatively ุงู„ุฃุตู„ ูŠุง ุดุจุงุจ ุฅู†ู‡ ุงู„ู†ุชุงุฆุฌ ุจูŠู†
359
00:33:02,100 --> 00:33:07,200
ุงู„ูุญูˆุตุงุช ุงู„ู…ุฎุชู„ูุฉ ุชุชูˆุงูู‚ ุจูŠู† ุงู„ูุญูˆุตุงุช ุงู„ู…ุฎุชู„ูุฉ
360
00:33:07,200 --> 00:33:12,460
ุชุชูˆุงูู‚ ูˆุนุฏู… ุชูˆุงูู‚ู‡ุง ุจูŠุนู†ูŠ ุฅู†ู‡ ุจูŠุฎู„ูŠู†ุง in shock ููŠ
361
00:33:12,460 --> 00:33:17,730
ุฅู†ู‡ ุงู„ von Willebrand ุงู„ู„ูŠ ุงุญู†ุง ุจู†ุฏูˆุฑ ุนู„ูŠู‡ ู‡ูˆ ู…ู† ุงู„ู†ูˆุน
362
00:33:17,730 --> 00:33:21,610
ุงู„ qualitative type ู…ุด ุงู„ quantitative ูŠุนู†ูŠ type
363
00:33:21,610 --> 00:33:26,610
two ู…ุด type ูˆุงุญุฏ ุฃูˆ ุงูŠุด ุฃูˆ ุงุซู†ูŠู† ูˆู‡ูŠ type two
364
00:33:26,610 --> 00:33:31,070
ุนุดุงู† ู†ุดุฎุต ุจุงู„ุธุจุท ุฃูŠ ู†ูˆุน ู…ู†ู‡ ุจุฏู†ุง ู†ุนู…ู„ further
365
00:33:31,070 --> 00:33:35,610
investigation ุตุญุŸ ู„ุชุงู„ูŠ ุจุฏู†ุง ู†ุชุงุจุน ูˆ ู†ุดูˆู ุงูŠุด ุงู„
366
00:33:35,610 --> 00:33:40,050
investigation ูุจุงู„ู‚ูŠู… ู†ุฏุฑุณ ุงู„ multimer forms
367
00:33:40,050 --> 00:33:45,270
ุงู„ู…ุฎุชู„ูุฉ ููŠ ุงู„ von Willebrand ูˆุจู†ุฏุฑุณู‡ุง ุจูˆุงุณุทุฉ
368
00:33:45,270 --> 00:33:50,030
ุจูุญุตุŒ ุงูŠุดุŸ
369
00:33:50,030 --> 00:33:53,390
ูƒูŠู ุจุฏูƒ ุชุนุฑู ุงู„ุฃู†ูˆุงุน ุงู„ู…ุฎุชู„ูุฉ ู…ู† ุงู„ multimer ููŠ
370
00:33:53,390 --> 00:34:04,030
ุงู„ุฏู†ูŠุงุŸ ุจูุญุต ุงู„ electrophoresisุŸ
371
00:34:05,010 --> 00:34:07,150
ูˆุงู†ุชุด ู‡ุงูƒ ุนู„ูŠู‡ุง ู‡ูŠ electrophoresis ูุงู†ุง ุฃู‚ูˆู„ ุงู„ู„ูŠ
372
00:34:07,150 --> 00:34:11,070
ู‡ูˆ paper ู‡ูŠ electrophoresis ุงู„ electrophoresis
373
00:34:11,070 --> 00:34:15,850
ุจุชุนุฑููˆุง ุงู„ principle ุชุจุนู‡ ุจูŠุตูŠุฑ ุนู…ู„ูŠุฉ ูุตู„ between
374
00:34:15,850 --> 00:34:22,050
different components ุจู†ุงุก ุนู„ู‰ ุงู„ charge ูˆ ุงู„
375
00:34:22,050 --> 00:34:27,610
size ูู‡ุฐุง ู‡ูˆ ุงู„ูุญุต ุดุงูŠููŠู† ุงู„ูุญุต ูŠุง ุดุจุงุจุŸ ุดุงูŠููŠู†
376
00:34:27,610 --> 00:34:32,390
ุงู„ุตูˆุฑุฉุŸ ู‡ุฐุง normal ู‡ูŠ ุนุจุงุฑุฉ ุนู† multimers ูƒู„ ูˆุงุญุฏ
377
00:34:32,390 --> 00:34:38,380
.. ูƒู„ ..ูƒู„ form ุฃุฎุฏ ุนูŠุงุด band ุดุงูŠููŠู† ุงู„ patient
378
00:34:38,380 --> 00:34:44,680
ู‚ุฏุงุด ู†ุต ุงู„ุนูŠุงุด ุงู„ normal ู†ุต ุงู„ุนูŠุงุด ุงู„ normal
379
00:34:44,680 --> 00:34:54,040
ุจุงู„ุชุงู„ูŠ ู…ู…ูƒู† ู†ุดุฎุต ู…ู†ู‡ ุจุณู‡ูˆู„ุฉ treatment ุจูŠุนุงุฌูˆุง
380
00:34:54,040 --> 00:35:00,720
ุงู„ู…ุฑุถ ู‡ุฐุง ุจุงู„ DDAVB ุฎุฏู†ุงู‡ ุงู„ู…ุฑุถ ู‡ุฐูŠูƒ ูˆู‚ูˆู„ู†ุง ู‡ูŠุด
381
00:35:00,720 --> 00:35:08,140
ุจุนู…ู„ุฎุฏู†ุงูƒ ุนู„ุงุฌ ู„ู…ุฑุถู‰ ุงู„ู‡ู…ูˆููŠู„ูŠุง ู…ุฑุถู‰ ุงู„ู‡ู…ูˆููŠู„ูŠุง
382
00:35:08,140 --> 00:35:13,080
ุนู†ุฏู‡ู… ู†ู‚ุต ููŠ factor 8 ูˆู‚ูˆู„ู†ุง ุงู„ู†ุงุณ ุงู„ู„ูŠ ุนู†ุฏู‡ู… mild
383
00:35:13,080 --> 00:35:19,860
hemophilia ู†ุฏูŠู‡ู… DDABB ุนุดุงู† ุจุงู„ุธุจุท ุจุชุทู„ุน ุงู„ููˆู…
384
00:35:19,860 --> 00:35:23,580
ุงู„ุงุจุฑู‡ู† ู…ู† ู…ุฎุงู„ุจู‡ ูุจูŠุฒูˆุฏ ุงู„ููˆู… ุงู„ุงุจุฑู‡ู† ุงู„ู„ูŠ ุจุฏู‡
385
00:35:23,580 --> 00:35:27,980
ูŠุญู…ูŠ ุงู„ูƒู…ูŠุฉ ุงู„ู‚ู„ูŠู„ุฉ ู…ู† factor 8 ุทูŠุจ ูŠุนู†ูŠ ู‡ูˆ ุจูŠุฒูˆุฏ
386
00:35:27,980 --> 00:35:30,500
ุงู„ููˆู… ุงู„ุงุจุฑู‡ู† ุทุจ ุงู„ุฃูˆู„ู‰ ุฃู†ู‡ ู†ุนุงู„ุฌ ู…ุฑูŠุถ ุงู„ููˆู…
387
00:35:30,500 --> 00:35:36,720
ุงู„ุงุจุฑู‡ู† ูŠุง ุจุงุจุงุŒ ู…ุฌุจูˆุทุŸูุจุงู„ุชุงู„ูŠ ู‡ูˆ ุนู„ุงุฌ ู„ู„ Vomit
388
00:35:36,720 --> 00:35:40,940
Cryoprecipitate ู‡ูˆ ุจุฑู‡ ุงู† ุงุญุฏ ุงู„ blood
389
00:35:40,940 --> 00:35:46,140
component ุจูŠุญุชูˆูŠ ุนู„ู‰ ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู† ุงู„ Factor VIII Cryoprecipitate
390
00:35:46,140 --> 00:35:49,740
ูุงูƒุชูˆุฑ ุชู…ุงู†ูŠุฉ concentrate ุจุฑุถู‡ ุงุญุฏ ุงู„ plasma
391
00:35:49,740 --> 00:35:57,740
component ุงู„ู„ู‰ ุจูŠุญุถุฑ ุงู„ุชุญุถูŠุฑ ุจุงู„ู…ุตุงู†ุน ูˆ ุจูŠุญุชูˆูŠ
392
00:35:57,740 --> 00:36:02,830
ุงูŠุถุง ุนู„ู‰ ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู† ุงูŠุดุŸ ู…ู† ุงู„ Factor VIII Concentrate ุทุจุนุง
393
00:36:02,830 --> 00:36:09,410
ุดุจุงุจ ู‡ุฐุง ุงู„ treatment ุงูˆู„ ุตูุญุชูŠู† ูˆ ุงู„ุชุงู„ุชูŠู† ู‡ุฐุง ูˆ
394
00:36:09,410 --> 00:36:15,210
ู‡ุฐุง ูŠุนู†ูŠ ูƒูŠููŠุฉ ุงู„ุนู„ุงุฌ
395
00:36:15,210 --> 00:36:20,510
ูˆ ุงู„ protocol ุงู„ุนู„ุงุฌ ูˆ ูƒุฏู‡ุด ู„ุงุฒู… ู†ุนุทูŠ ูŠุนู†ูŠ ู…ุด ูƒุชูŠุฑ
396
00:36:20,510 --> 00:36:26,390
ุงุญู†ุง ู…ุนุงู†ูŠู† ููŠู‡ ู‡ู†ุง ุจู‚ู‰ ูƒู…ุงู† ู…ู† ุงู„ treatment ู‡ุฏุง
397
00:36:26,390 --> 00:36:30,190
ู‡ูŠ ุงู„ platelet transfusion ุงู†ูƒ ุชุนุทูŠ platelet ู…ุธุจูˆุท
398
00:36:30,190 --> 00:36:33,990
ูˆุงุญุฏ ุนู†ุฏู‡ ูƒู…ูŠุฉ ุงู„ Factor VIII ู‚ู„ูŠู„ุฉ ุทุจ ุฒูˆุฏ ุงู„
399
00:36:33,990 --> 00:36:42,030
platelet ู…ุงุดูŠ ุนุดุงู† ุงูŠู‡ุŸ ุนุดุงู† ูŠุชุฒูˆุฏ ุงู„ู„ูŠ ู‡ูˆ ุงู„ Factor VIII
400
00:36:42,030 --> 00:36:45,450
ู„ุฃู†ู‡ ูƒู…ุงู† ุงู„ platelet ุชุญุชูˆูŠ ุนู„ู‰ Factor VIII
401
00:36:45,450 --> 00:36:49,110
ุทุจ ู…ุง cryoprecipitate ู‚ู„ู†ุง ุนุจุงุฑุฉ ุนู† ู‡ูˆ
402
00:36:49,110 --> 00:36:52,930
ุฌุฒุก ู…ู† ุงู„ human plasma ุจูŠุญุชูˆูŠ ุนู„ู‰ ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู† ุงู„
403
00:36:52,930 --> 00:36:57,750
factor 8 ูˆ Factor VIII ูˆ ุงู„ fresh frozen plasma
404
00:36:57,750 --> 00:37:02,820
ุฃูŠุถุงุจูŠุญุชูˆูŠ ุนู„ู‰ ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู† ุงู„ Factor VIII ูˆ ู…ู† ุงู„ุฃุจู†ุงุก
405
00:37:02,820 --> 00:37:09,300
ุงุญุฏ ุนู†ุฏู‡ ุณุคุงู„ุŸ
406
00:37:09,300 --> 00:37:14,520
ุญุฏ ุนู†ุฏู‡ ุณุคุงู„ ูŠุง ุดุจุงุจุŸ
407
00:37:14,520 --> 00:37:20,740
ุทูŠุจ ู†ูƒู…ู„ ููŠ ุงู„ DIC DIC ุงุฎุชุตุงุฑ ู„ disseminate
408
00:37:20,740 --> 00:37:27,680
Intravascular Coagulation ู…ุงุดูŠ disseminated
409
00:37:27,680 --> 00:37:28,400
Intravascular
410
00:37:34,790 --> 00:37:40,590
Syndrome ุจูŠุชู…ูŠุฒ ุจู€ SystemicุŒ ุฅูŠุด ูŠุนู†ูŠ SystemicุŸ
411
00:37:40,590 --> 00:37:45,410
ูŠุนู†ูŠ ูƒู„ ุงู„ุฌุณู… ุฏู‡ุŒ ู…ุงุดูŠุŒ ูŠู†ุชุดุฑ Intravascular
412
00:37:45,410 --> 00:37:52,090
Coagulopathy ุฌู„ุทุงุช ู…ู†ุชุดุฑุฉ ููŠ ุฌู…ูŠุน ุฃู†ุญุงุก ุงู„ุฌุณู…ุŒ
413
00:37:52,090 --> 00:37:59,420
ูŠุนู†ูŠ ุจุฏุงูŠุชู‡ ุฅูŠุดุŸ ุฌู„ุทุฉุŒ ู…ุงุดูŠุŸ and clotting
414
00:37:59,420 --> 00:38:04,060
initial event ูŠุนู†ูŠ ุงู„ุญุฏุซ ุงู„ุฃูˆู„ู‰ ู‡ูˆ ุฅูŠุดุŸ ู‡ูˆ clot
415
00:38:04,060 --> 00:38:09,640
formation ูˆู…ุนุธู… ุงู„ูˆููŠุงุช ุจุชุนุชู…ุฏ ุนู„ู‰ ุงู„ extent of
416
00:38:09,640 --> 00:38:13,460
intravascular thrombosisุŒ ุฌุฏุงุด ุตุงุฑ ููŠู‡ ุฌู„ุทุงุช
417
00:38:13,460 --> 00:38:21,440
ุงู„ูˆููŠุงุช ุจุชุนุชู…ุฏ ุนู„ู‰ ุฅูŠุดุŸ ุฌุฏุงุด ุตุงุฑ ููŠู‡ ุฌู„ุทุงุช ูˆู…ู†
418
00:38:21,440 --> 00:38:26,100
ุฃุณุจุงุจู‡ .. ุฃุณุจุงุจู‡ ู…ุชุนุฏุฏุฉ ุฃุณุจุงุจู‡ ู…ุชุนุฏุฏุฉ ุนู†ุฏ ุญุฏ ุฃู†ุง
419
00:38:26,100 --> 00:38:26,960
ุชุทุฑู‚ ุฅู„ูŠู‡ุง
420
00:38:31,540 --> 00:38:35,940
ุจุชู†ุชุดุฑ ุจุดูƒู„ ุณูŠุณุชูŠู…ูŠูƒ ููŠ ุฌู…ูŠุน ุญุงู„ุฉ ุงู„ุฌุณู… ูˆุญุณุจ
421
00:38:35,940 --> 00:38:42,020
ุงู†ุชุดุงุฑู‡ุง ุจุชุนุชู…ุฏ ุญุงู„ุงุช ุงู„ูˆูุงูŠุฉ ุนู„ู‰ ุงู†ุชุดุงุฑ ู‡ุฐู‡
422
00:38:42,020 --> 00:38:48,920
ุงู„ุฌุจุทุงุช ูˆุงุณุจุงุจู‡ู… ู…ุชุนุฏุฏุฉ ุทูŠุจ acquired syndrome
423
00:38:48,920 --> 00:38:52,580
ุจุชุชู…ูŠุฒ ุจู€ Intravascular Coagulability ูˆู‡ุฐุง ุงู„ู„ูŠ
424
00:38:52,580 --> 00:38:56,600
ุชุงูˆู… ุญุงูƒูŠู†ุงู‡ ูƒู„ู‡ ู…ู‡ู… ุดูˆููˆุง ูƒูŠู ุจุชุชู… ุงู„ุญูƒุงูŠุฉ ุดุจูƒุฉ
425
00:38:56,600 --> 00:39:00,180
ุชู†ุชุจู‡ ุนู„ูŠู‡ุง ู‡ูŠ Systemic Activation of Coagulation
426
00:39:01,270 --> 00:39:07,450
Cascade Systemic ูŠุนู†ูŠ ุฅูŠุดุŸ ููŠ ูƒู„ู‡ุงุŒ ุจุงู„ุธุจุทุŒ ู…ุด
427
00:39:07,450 --> 00:39:11,830
localized ู‡ุฐุง ุจูŠุคุฏูŠ ุฅู„ู‰ Intravascular ุจุนุฏ ูุชุฑุฉ
428
00:39:11,830 --> 00:39:17,050
ุจุชุถู„ ุชุนู…ู„ ุฌู„ุทุฉุŒ ุชุนู…ู„ ุฌู„ุทุฉุŒ ุชุนู…ู„ ุฌู„ุทุฉ ุงู„ู…ูˆุงุฏ ุงู„ุฎุงู…
429
00:39:17,050 --> 00:39:24,510
ุจุชุถู„ ู…ูˆุฌูˆุฏุฉุŒ ุจุชุฎู„ุตุŒ ุตุญุŸ ูุจุฏุฃ ุฌุจู„ ู…ุง ุชุฎู„ุต ูŠุตูŠุฑ ููŠู‡
430
00:39:24,510 --> 00:39:28,830
Intravascular Deposition of Fibrin ุจุชูƒูˆู† ุฌู„ุทุงุช ู…ู†
431
00:39:28,830 --> 00:39:34,400
ุงู„ fibrin ููŠ ุฃู…ุงูƒู† ู…ุชุนุฏุฏุฉThrombosis of small and
432
00:39:34,400 --> 00:39:41,320
mid-sized vessel ูˆู‡ูˆ ูŠุคุฏูŠ ุฅู„ู‰ ischemia ูˆ organ
433
00:39:41,320 --> 00:39:47,360
failureุŒ ู…ุธุจูˆุทุŸ ู„ูƒู† ุฒูŠ ู…ุง ู‚ู„ุชู„ูƒูˆุงุŒ ุงุณุชู…ุฑุงุฑ ู‡ุฐู‡
434
00:39:47,360 --> 00:39:54,840
ุงู„ุญุงู„ุฉ ุจูŠุชุทู„ุจ ุฃูˆ ุจูŠุชุจุนูˆุง ุฃู† ุงู„ู…ูˆุงุฏ ุงู„ุฎุงู…ุฉ ุชุฎู„ุต ู…ู†
435
00:39:54,840 --> 00:39:58,520
ุงู„ู€platelet ูˆ ุงู„ coagulation factor ูˆุฅุฐุง ุฎู„ุตู‡ุงุŒ
436
00:39:58,520 --> 00:40:02,920
ูŠุฎุด ุงู„ู…ุฑูŠุถ ููŠ ุฅูŠู‡ุŸ ููŠ bleedingูˆุงู„ุงุชู†ูŠู† ุจูŠุนุฏูˆุง
437
00:40:02,920 --> 00:40:06,640
ู„ู„ูˆูุงุฉ
438
00:40:06,640 --> 00:40:13,700
ุนูŠุฏ ุชุงู†ูŠ ุนูŠุฏ ุชุงู†ูŠ Systemic ุงุญู†ุง ุจู†ู‚ูˆู„
439
00:40:13,700 --> 00:40:18,440
Intravascular Coagulopathy ูŠุนู†ูŠ ููŠ activation
440
00:40:18,440 --> 00:40:21,620
ุงู„ coagulation cascade mechanism ููŠ ู…ูƒุงู† ูˆุงุญุฏ ููŠ ุงู„ุฌุณู…
441
00:40:21,620 --> 00:40:27,120
ู„ุฃ ููŠ ุฃู…ุงูƒู† ู…ุฎุชู„ูุฉ ูู…ุญุตู„ุฉ ู†ุดุงุท ุงู„ coagulation cascade
442
00:40:27,120 --> 00:40:32,080
ุชูƒูˆูŠู† thrombin ูŠุนู†ูŠ ููŠ ุฌู„ุทุงุชูˆุฅุฐุง ุตุงุฑ ููŠู‡ fibrin
443
00:40:32,080 --> 00:40:38,780
formation ุดูˆ ุจูŠุนู…ู„ุŸ ุฌู„ุทุงุช ููŠ ุงู„ small ูˆ ุงู„ mid
444
00:40:38,780 --> 00:40:45,740
-sized vessel ู‡ุฐุง ุจูŠุคุฏูŠ ู„ูŠุดุŸ ischemia 100% ูˆุฅุฐุง ุตุงุฑ ููŠู‡
445
00:40:45,740 --> 00:40:50,520
ischemia ููŠู‡ organ failure ุงุณุชู…ุฑุช ุงู„ุญูƒุงูŠุฉ ู‡ูŠุคุฏูŠ
446
00:40:50,520 --> 00:40:54,000
ุฅู„ู‰ depletion of coagulation factor and platelet
447
00:40:54,000 --> 00:40:59,780
ูˆู‡ุฐุง ุจูŠุคุฏูŠ ุฅู„ู‰ bleeding ูˆู‚ู„ุช ู„ูŠู‡ุŸ ุทุจุนุง ุณูˆุงุก ูƒุงู†ุช
448
00:40:59,780 --> 00:41:06,100
ุฌู„ุทุฉุฃูˆ ุงุณูƒูŠู…ูŠุง ูˆ ุงู„ู€ bleeding ุจุณุจุจ ุงู„ูˆูุงุฉ
449
00:41:06,100 --> 00:41:09,820
pathophysiology
450
00:41:09,820 --> 00:41:15,400
of DIC ูƒูŠู ูŠุชู… ุชุฑุชูŠุจ ุงู„ู…ูŠูƒุงู†ูŠุฒู… ูƒูŠู ุชู… ุชุฑุชูŠุจู‡
451
00:41:15,400 --> 00:41:19,360
ู‚ุงู„ูŠุชู‡ activation of blood coagulation ู…ุง ุงุชูู‚ู†ุง
452
00:41:19,360 --> 00:41:23,680
ุซู… suppression of physiological anticoagulant ูƒู„
453
00:41:23,680 --> 00:41:27,760
ุงู„ู€ anticoagulant ููŠ ุงู„ุจุฏุงูŠุฉ ู…ุซู„ ุงู„ู€ unblocking
454
00:41:27,760 --> 00:41:33,020
ุดุบุงู„ุงู„ู€ Coagulant ุงู„ู€ Pro-Coagulant ูŠุดุบู‘ู„ ุงู„ู€ Anti
455
00:41:33,020 --> 00:41:37,000
-Coagulant ูˆ ุฃู‚ูู„ ูˆู‡ูŠ ุจูŠุตูŠุฑ ููŠู‡ impairment ู„ู„ู€
456
00:41:37,000 --> 00:41:40,500
Fibrinolysis ูŠุนู†ูŠ ู…ุงููŠุด ุฅุฐู‡ุงุจ ู„ู„ุฌู„ุทุฉ ุฃุญู†ุง ู‚ู„ู†ุง ุงู„ู€
457
00:41:40,500 --> 00:41:43,420
Fibrinolysis ู…ู…ูƒู† ูŠุนู…ู„ ุงู„ bleeding ู…ุงููŠุด ุฅุฐู‡ุงุจ
458
00:41:43,420 --> 00:41:48,700
ู„ู„ุฌู„ุทุฉ ู„ูƒู† ุจูŠุตูŠุฑ ูƒู…ุงู† cytokine release ูˆู†ุดูˆู ูˆุงุญุฏ
459
00:41:48,700 --> 00:41:52,620
ูˆุงุญุฏ ู‡ุฐู‡ ุงู„ุนูˆุงู…ู„ ุดูˆ ุจุชุฃุซุฑ activation ูˆ blood
460
00:41:52,620 --> 00:41:56,280
coagulation ูŠุง ุดุจุงุจ ูƒูŠู ู…ู…ูƒู† ูŠุตูŠุฑ blood
461
00:41:56,280 --> 00:41:56,920
coagulation
462
00:41:59,650 --> 00:42:05,770
Cascade Activation Tissue Factor ุตุญุŸ ูˆู‡ุฐู‡ ู…ู† ุฃุฎุทุฑ
463
00:42:05,770 --> 00:42:11,790
ุงู„ุญุงุฌุงุช ุงู„ู„ูŠ ุจุชุตูŠุฑ ูŠุง ุดุจุงุจ ุงู†ู‡ ู…ุฑูŠุถ ู„ุณุจุจ ู…ุง ูŠุตูŠุฑ
464
00:42:11,790 --> 00:42:16,250
blood vessel injury ูˆ ุจ release of tissue factor ูˆ
465
00:42:16,250 --> 00:42:20,210
ุฅุฐุง ุณูˆุตู„ ุงู„ tissue factor ู„ู„ุฏู… ู…ู…ูƒู† ูŠุณุจุญ ููŠ ุงู„ุฏู… ูˆ
466
00:42:20,210 --> 00:42:25,210
ูŠุตูŠุฑ ูŠูƒูˆู† ุฌู„ุทุงุช ููŠ ู…ู†ุงุทู‚ ู…ุฎุชู„ูุฉ ู…ู† ุงู„ุฌุณู… ุตุญุŸ ูู‡ูŠ
467
00:42:25,210 --> 00:42:31,330
tissue factor factor 7A Thrombin generation ูŠุชู…
468
00:42:31,330 --> 00:42:39,490
ุชู†ุดูŠุทู‡ ู…ู† ุฎู„ุงู„ ุงู„ู€ Extrinsic pathway ูˆ ุจุฐูƒุฑูƒู… ุงู†
469
00:42:39,490 --> 00:42:46,150
ุงู„ Extrinsic is very short ูŠุนู†ูŠ ู„ุชู†ุดูŠุทู‡ ุจุณุฑุนุฉ ุทุจุนุง
470
00:42:46,150 --> 00:42:50,330
complex activate factor 9 ูˆ factor 10 ูˆ ุชุดูˆู
471
00:42:54,770 --> 00:43:00,010
in multiple places ู…ุงุดูŠ ูŠุนู†ูŠ ู…ูˆุฌูˆุฏ ููŠ ุฃู…ุงู‚ ู…ุฎุชู„ูุฉ
472
00:43:00,010 --> 00:43:04,330
ู…ู† ุงู„ุฌุณู… ููŠ ุงู„ endothelial cells ููŠ ุงู„ monocytes ูˆ
473
00:43:04,330 --> 00:43:07,410
extravascularly ู…ูˆุฌูˆุฏ ููŠ ุงู„ lung ูˆ ุงู„ kidney ูˆ ุงู„
474
00:43:07,410 --> 00:43:10,230
brain ูˆ ุงู„ endothelial cell ุงู„ epithelial cell
475
00:43:10,230 --> 00:43:15,870
ู…ุงุดูŠ ู‡ุฐู‡ ู…ูˆุงู‚ุน ุญุณุงุณุฉ ูˆ ุงู„ uterus ู…ูˆุงู‚ุน ุญุณุงุณุฉ
476
00:43:15,870 --> 00:43:20,730
ู…ู„ูŠุงู†ุฉ ุจุงู„ุงุด ู…ู† ุงู„ tissue factor ูŠุจู‚ู‰ ู†ู…ุฑุง ูˆุงุญุฏ
477
00:43:20,730 --> 00:43:23,590
activation of blood coagulation through tissue
478
00:43:23,590 --> 00:43:27,430
factor release ุงู„ู„ูŠ ุจูŠูƒูˆู† extra vascular ูˆ ุจุชู‚ูˆู…
479
00:43:27,430 --> 00:43:30,890
ูŠุตู„ู„ ุงู„ vascular ูŠุนู†ูŠ ุจูŠุตู„ู„ ุงู„ุฏู… ูˆ ู‡ู†ุงูƒ ุจูŠูƒูˆู‘ู†ุด
480
00:43:30,890 --> 00:43:36,690
thrombin formation ูˆ fibrin formation ู†ู…ุฑุง ุงุชู†ูŠู†
481
00:43:36,690 --> 00:43:40,050
ุนุดุงู† ุจู‚ู‰ ุจูŠุตูŠุฑ ููŠู‡ suppression ู„ู„ anticoagulant
482
00:43:40,050 --> 00:43:46,690
pathway ูˆ ุจูŠุชู…ุซู„ ุจ reduction of antithrombin 3
483
00:43:49,380 --> 00:43:52,540
ูƒู…ุงู† ุจูŠุตูŠุฑ ููŠู‡ impairment ู„ protein C ูˆ protein S
484
00:43:52,540 --> 00:43:57,880
ูˆ ู‡ุฏูˆู„ุฉ ูƒู„ู†ุง ุจู†ุนุฑูู‡ู… ุตุญุŸ ูˆ ุจุฑุถู‡ ู…ุด ุชู„ูƒ
485
00:43:57,880 --> 00:44:02,620
anticoagulant ุทุจุนุงุŒ ุซู… ุจูŠุตูŠุฑ ููŠู‡ insufficient of
486
00:44:02,620 --> 00:44:04,640
regulation of tissue factor pathway inhibitor
487
00:44:04,640 --> 00:44:12,420
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ inhibition ู„ุงู„ู€ TFPI ูŠุนู†ูŠุŒ
488
00:44:12,420 --> 00:44:12,840
ุนุงุฑููŠู†ุŸ
489
00:44:15,550 --> 00:44:19,450
ุงู„ุชุงู†ูŠุฉ Impaired FibrinolysisุŒ ู…ูŠู† ุจูŠุนู…ู„
490
00:44:19,450 --> 00:44:27,250
FibrinolysisุŸ Plasminogen activator ุจูŠุนู…ู„
491
00:44:27,250 --> 00:44:32,730
Fibrinolysis ุทูŠุจ ู„ูˆ ู†ุดุทู†ุง ุงู„ inhibitor ุจุชุงุน ุงู„
492
00:44:32,730 --> 00:44:36,830
activatorุŒ ุดูˆ ุจู†ุนู…ู„ุŸ 100%ุŒ 100%ุŒ ู‡ุฐุง ุงู„ู„ูŠ ุจูŠุตูŠุฑุŒ
493
00:44:36,830 --> 00:44:40,970
Impaired Fibrinolysis Cytokine release ุดุจุงุจ ุจุฑุถู‡
494
00:44:40,970 --> 00:44:45,750
ู…ูŠูƒุงู†ูŠุฒู… ุฑุงุจุน ู†ุฌูˆุง ุงู†ู‡ ููŠ ุญุงู„ุงุช ุงู„ DIC ุจูŠุตูŠุฑ ููŠู‡
495
00:44:45,750 --> 00:44:50,410
secretion ู„ certain cytokines ู…ู†ู‡ุง ุงู„ IL-6 ูˆ IL-1
496
00:44:50,410 --> 00:44:57,430
ูˆ tumor necrosis factor ูˆ ู‡ุฐุง ุจูŠุนู…ู„ dysregulation
497
00:44:57,430 --> 00:45:03,150
ู„ู„ anticoagulant pathway ูˆ ูŠ modulate IL-6 IL-10
498
00:45:03,150 --> 00:45:07,610
ูƒู…ุงู† modulated activation coagulation factor ุฃูˆ
499
00:45:07,610 --> 00:45:10,630
coagulation cascade ูˆุจุงู„ุชุงู„ูŠ ูู‰ ุนู„ุงู‚ุฉ ู…ุจุงุดุฑุฉ ุฌุฏุง
500
00:45:10,630 --> 00:45:14,310
ู…ุง ุจูŠู† ุงู„ coagulation ูˆุงู„inflammation ุฃูˆ ุงู„
501
00:45:14,310 --> 00:45:20,950
inflammatory process ุทูŠุจ ูƒูŠู ู†ุดุฎุต ู…ุฑูŠุถ ุณุฑูŠุฑ ุนู†ุฏู‡
502
00:45:20,950 --> 00:45:26,450
DIC ู…ุฑูŠุถ ุณุฑูŠุฑ ุนู†ุฏู‡ DIC the brothers of disease
503
00:45:26,450 --> 00:45:34,530
associated with DIC ุฏู‡ ู†ุดูˆู ุฅู† ุงู„ุงุทู„ุงุน ุนู„ู‰ ู…ุธุงู‡ุฑ
504
00:45:34,530 --> 00:45:41,000
ู…ุฑุถูŠุฉ ุจุชูƒูˆู† ู…ูˆุฌูˆุฏุฉ appropriate clinical setting
505
00:45:41,000 --> 00:45:46,040
ู„ู†ูุดูˆู ุฅุฐุง ูƒุงู† ููŠ ุฃูŠ evidence of thrombosis ุฃูˆ
506
00:45:46,040 --> 00:45:50,280
hemorrhage ู„ุฅู†ู‡ ู…ุฑุถ ู…ู† ู‡ุงู„ู†ูˆุน ูŠุจุฏุฃ ุณุงู„ุจ ุจุฌู„ุทุฉ
507
00:45:50,280 --> 00:45:55,960
ูˆูŠู†ุชู‡ูŠ ููŠู‡ ุจู€ bleeding laboratory studies no single
508
00:45:55,960 --> 00:46:00,020
test is accurate serial tests are more helpful
509
00:46:00,020 --> 00:46:06,140
than single test ูŠุฌุจ ุฃู† ุชุนู…ู„ ู…ุฌู…ูˆุนุฉ ู…ู† ุงู„ูุญูˆุตุงุช ูˆู…ู†
510
00:46:06,140 --> 00:46:11,440
ุฃุณุจุงุจู‡ ูŠุง ุดุจุงุจ ุดูˆููˆุง ุฃุณุจุงุจู‡ ุฅูŠุด ู…ุงู„ูƒ ู†ุงู†ุณูŠ release
511
00:46:11,440 --> 00:46:16,380
of tissue factor cardiovascular hypothermia or
512
00:46:16,380 --> 00:46:19,760
hyperthermia ุงู„ู†ุงุณ ุงู„ู„ูŠ ู…ุชุนุฑุถุฉ ู„ุฏุฑุฌุฉ ุญุฑุงุฑุฉ ูˆุงุทูŠุฉ
513
00:46:19,760 --> 00:46:24,300
ุฃูˆ ุนุงู„ูŠุฉ ุงู„ู…ู†ุฑูŠ acute respiratory distress
514
00:46:24,300 --> 00:46:30,780
syndrome ุฃุณุฏูˆุณูŠุฒ ูˆุงู†ูƒุณูŠุง collagen vascular disease
515
00:46:30,780 --> 00:46:32,260
ูˆุงู†ูู„ุงูƒ
516
00:46:39,800 --> 00:46:43,720
ูƒู…ุงู† ู…ู† ุงู„ุฃุณุจุงุจ ุงู„ู„ูŠ ุจุชุคุฏูŠ ุฅู„ู‰ DIC infectious
517
00:46:43,720 --> 00:46:47,180
agent ุฒูŠ ุงู„ู€Septicemia ุณูˆุงุก ูƒุงู† ุจูƒุชูŠุฑูŠุง ุฃูˆ ุงู„ููŠู„ุฑ
518
00:46:47,180 --> 00:46:52,400
ุฃูˆ ุงู„ูู†ุฌุฑ ุซู… Intravascular Hemolysis ู„ุฅู†ู‡ ุจูŠุทู„ุน
519
00:46:52,400 --> 00:47:00,940
ุชุดูˆูุงูƒุชุฑ ุซู… acute liver disease ูˆุชุดูˆูุงูƒุชุฑ ูˆ
520
00:47:00,940 --> 00:47:05,540
Obstetric ู…ู† ุงู„ู…ุญุทุงุช ุงู„ู…ู‡ู…ุฉ ุฌุฏุง ูŠุง ุดุจุงุจ ู‡ูŠ ู…ุญุทุฉ
521
00:47:05,540 --> 00:47:11,140
ุงู„ูˆู„ุงุฏุฉ ู„ุฅู†ู‡ ููŠ ุงู„ูˆู„ุงุฏุฉ ุจุฅู…ูƒุงู†ูŠุฉ ุฅู†ู‡ ูŠุตูŠุฑ ููŠู‡
522
00:47:11,140 --> 00:47:19,320
tissue factor release ุนุงู„ูŠุฉ ุฌุฏุง ุฌุฏุง ุฌุฏุง ุทุจุนุง ุณูŠูุจู‚ู‰
523
00:47:19,320 --> 00:47:26,080
ุจู‡ุฐู‡ ุงู„ู€ symptoms ุงู„ู…ุฎุชู„ูุฉ ุงู„ุฌุณู… ุจุงู„ุฅู†ุณุงู† ูŠุนุงู†ูŠ ู…ู†
524
00:47:26,080 --> 00:47:29,500
different symptoms ู…ู…ูƒู† ู†ุดูˆูู‡ุง ููŠ ุงู„ู€ skin ููŠ ุงู„ู€
525
00:47:29,500 --> 00:47:33,380
central nervous system ููŠ ุงู„ู€ kidney ููŠ ุงู„ู€ heart ููŠ
526
00:47:33,380 --> 00:47:40,020
ุงู„ู€ pulmonary ููŠ ูƒู„ ุงู„ุญุงู„ุงุช ุงู„ู…ุฑุถูŠุฉ ุทุจุนุง ู…ุญุตู„ุชู‡ุง ููŠ
527
00:47:40,020 --> 00:47:45,880
ุงู„ุจุฏุงูŠุฉ ุงู„ู€ chemistry ู„ุฅู†ู‡ ููŠู‡ thrombosis ุซู… ููŠู‡
528
00:47:45,880 --> 00:47:51,280
bleeding ุนุดุงู† ูุนู„ูŠ ุณุจูŠู„ ุงู„ู…ุซุงู„ ุงู„ู€ skin ุฃูˆู„ ุดูŠุก
529
00:47:51,280 --> 00:47:56,900
ุจูŠุตูŠุฑ ููŠู‡ุง peritrophalminas ูˆุฌุงู†ุฌุฑูŠู† ู„ุฅู†ู‡ ููŠู‡
530
00:47:56,900 --> 00:48:03,140
ุฌู„ุทุฉ ุซู… ุจุนุฏ ุฐู„ูƒ ุจู†ุดูˆู ููŠ ุจุชุงุดูŠ ูˆecchymosis ู„ุฅู†ู‡
531
00:48:03,140 --> 00:48:08,250
ุตุงุฑ ููŠู‡ bleeding ูุงู‡ู…ูŠู† ุนู„ูŠู‡ุงุŸ ูู…ุฑูŠุถ ุงู„ู€ DIC ุจูŠู…ุฑ ููŠ
532
00:48:08,250 --> 00:48:14,250
ุนุฏุฉ ู…ุฑุงุญู„ ุญุณุจ ุงู„ู…ุฑุญู„ุฉ ุจูŠุตูŠุฑ ููŠู‡ symptoms ูˆุนู†ุฏู†ุง
533
00:48:14,250 --> 00:48:20,610
ุญุณุจ ุงู„ู…ุฑุญู„ุฉ ุจุชุดูˆู ู†ุชูŠุฌุฉ ูุญุต ู„ุฅู† ููŠ ูƒู„ ู…ุฑุญู„ุฉ ููŠ ูุญุต
534
00:48:20,610 --> 00:48:27,310
ู…ุฎุชู„ู ููŠ ู†ุชูŠุฌุฉ ู…ุฎุชู„ูุฉ ูˆุญุณุจ ุงู„ู…ุฑุญู„ุฉ ุจูŠุชุนุงู„ุฌ ู…ุงุดูŠุŸ
535
00:48:27,310 --> 00:48:30,410
ูŠุนู†ูŠ ู…ุฑูŠุถ ู…ุซู„ุง ู‚ุงุนุฏ ุจูŠุนู…ู„ ุฌู„ุทุฉ ู…ู†ู‡ ุจูŠู‚ูˆู„ ุฃู†ุช ..
536
00:48:30,410 --> 00:48:33,550
ุฃู†ุช .. ูƒูˆุงุฌู„ ู„ูƒู† ู…ุฑูŠุถ ุฎุงุด ููŠ bleeding
537
00:48:37,810 --> 00:48:44,090
ุจุงู„ุชุงู„ูŠ ุญุณุจ ุงู„ู…ุฑุญู„ุฉ ุจุชุชุฃุซุฑ ุชุทู„ุน ู†ุชูŠุฌุฉ ุงู„ูุญุต ูˆุฅูŠุด
538
00:48:44,090 --> 00:48:51,410
ูˆุฃูˆู„ ุดูŠุก ุงู„ู€ symptoms ุซู… ู†ุชูŠุฌุฉ ุงู„ูุญุต ุซู… ุงู„ุนู„ุงุฌ ูˆ
539
00:48:51,410 --> 00:48:54,750
ู‡ุฐู‡ ู…ุธุงู‡ุฑ ู…ุฑุถูŠุฉ ุดุงูŠููŠู† ุงู„ุตูˆุฑุŸ ุจุฑู†ุงู…ุฌ ุฏูŠ ุจุตูˆุฑ ู„ุงุญู‚ุด
540
00:48:54,750 --> 00:48:58,950
ุฃู†ุง ููŠ bleeding ูˆุจุชุงุดูŠ ุจุชุงุดูŠ ูˆุงูƒูŠู…ูˆุฒุฉ ุดุงูŠููŠู†
541
00:48:58,950 --> 00:49:03,740
ุจุชุงุดูŠ ูˆุงูƒูŠู…ูˆุฒุฉุŸ ู‡ุฐู‡ ู…ุฑุญู„ุฉ ู…ุชู‚ุฏู…ุฉ ู‡ูŠ gangrenous
542
00:49:03,740 --> 00:49:10,640
ุดุงูŠููŠู† ุฅู† ุตุงุฑ ููŠ microvessels from pie ูˆุจุงู„ุชุงู„ูŠ
543
00:49:10,640 --> 00:49:17,780
ุฃุฏุช ุฅู„ู‰ ุฅู† ุจูŠุตูŠุฑ ููŠู‡ ุนู†ุฏู‡ gangrenous ุทุจุนุง
544
00:49:17,780 --> 00:49:21,920
ูƒู…ุงู† ู…ู† ุงู„ุญุงุฌุงุช ุงู„ู„ูŠ ุจูŠุตูŠุฑ ุฅู† ุงู„ู€ blood film ู„ูˆ
545
00:49:21,920 --> 00:49:24,820
ุนู…ู„ุช blood film ูŠุง ุดุจุงุจ ุจุชู„ุงู‚ูŠ microscopic finding
546
00:49:24,820 --> 00:49:26,560
schistocytes
547
00:49:29,720 --> 00:49:33,060
fragmentsุŒ ุดูŠุณุชูŠูˆ ุณุงูŠุฒุŒ pausty ุฃูˆ plateletุŒ ุฅูŠุด
548
00:49:33,060 --> 00:49:41,440
ูŠุนู†ูŠ paustyุŸ ู‚ู„ุฉ ููŠ ุงู„ู€ plateletุŒ ูˆููŠ ุญุงุฌุงุช ู‚ูˆู„ู†ุง
549
00:49:41,440 --> 00:49:45,170
ุฅู† single test is not enough ู…ู†ู‡ุง D-Diamar,
550
00:49:45,290 --> 00:49:49,870
Antithrombin 3, Fibrin monoxide A ูˆB, FTB,
551
00:49:50,030 --> 00:49:53,570
Platelet count, Protamine testุŒ ูƒู„ ุนุจุงุฑุฉ ุนู† ูุญูˆุตุงุช
552
00:49:53,570 --> 00:50:05,490
ู…ุฎุชู„ูุฉ ุจุชุทู„ุจ ูˆุจุงู„ุชุงู„ูŠ ุจุชุดุฎุต ุญุณุจ ู†ุชูŠุฌุฉ ุงู„ูุญูˆุตุฉุŒ
553
00:50:05,490 --> 00:50:10,310
ุจู†ุนุฑู ููŠ ุฃูŠ ู…ุฑุญู„ุฉ ุงู„ู…ุฑูŠุถ ูˆุตู„ุŒ ููŠ ุฃูŠ ู…ุฑุญู„ุฉ ุงู„ู…ุฑูŠุถ
554
00:50:10,310 --> 00:50:16,790
ูˆุตู„ุŒ ู…ู…ูƒู† ูŠุญุตู„ ุนู†ุฏู‡ thrombocytopenia ู…ู…ูƒู† ูŠุญุตู„ ููŠู‡
555
00:50:16,790 --> 00:50:20,650
prolongation ููŠ ุงู„ู€ BT ูˆBTT ุทุจุนุง ู‡ูˆ ูƒู„ู‡ ุงุณุชู‡ู„ูƒ
556
00:50:20,650 --> 00:50:27,630
ู…ุธุจูˆุท ู…ู…ูƒู† ู†ุดูˆู FDB ุฃูˆ D-Diamond ู†ุดูˆู low level of
557
00:50:27,630 --> 00:50:31,030
anticoagulant ุฒูŠ ุงู„ู€ Antithrombin 3 ุฃูˆ ุงู„ุจุฑูˆุชูŠู† C
558
00:50:31,030 --> 00:50:35,970
ูˆู„ูˆ ูุญุตู†ุง ุงู„ุนูˆุงู…ู„ ุงู„ู…ุฎุชู„ูุฉ ุฎู…ุณุฉ ุฃูˆ ุซู…ุงู†ูŠุฉ ุฃูˆ ุชุณุนุฉ
559
00:50:35,970 --> 00:50:42,040
ูƒู„ู‡ุง ู…ู„ุงุฌุฆุฉ ูˆุงุทูŠุฉ ูˆุงู„ู€ Fibrinogen ุงู„ูˆุญูŠุฏ ุงู„ู„ูŠ ู‡ูŠ ู„ุง
560
00:50:42,040 --> 00:50:46,300
ูŠููŠุฏ ููŠ ุงู„ุชุดุฎูŠุต ู„ุฃู† ูƒู…ูŠุชู‡ ูƒุจูŠุฑุฉ ูˆุงุณุชู‡ู„ุงูƒู‡ ุจูŠุทูˆู„
561
00:50:46,300 --> 00:50:49,540
ูˆุจุงู„ุชุงู„ูŠ
562
00:50:49,540 --> 00:50:55,460
ู…ููŠุฏุด ููŠ ุงู„ุชุดุฎูŠุต differential dialysis ุถุฑูˆุฑูŠ ุฌุฏุง
563
00:50:55,460 --> 00:51:00,240
ุนุดุงู† ุชุดุฎุต DIC ุชุชูุฑุฌ ุจูŠู† ุงู„ู€ DIC ูˆุงู„ู…ุฑุถ ุงู„ุฃู‡ู„ูŠ ุฒูŠ
564
00:51:00,240 --> 00:51:05,060
ุงู„ู€ severe liver failure ุดูˆ ุงู„ุตูุฉ ุงู„ู…ุดุชุฑูƒุฉ ุจูŠู†ู‡ ูˆุจูŠู†
565
00:51:05,060 --> 00:51:06,100
ุจูŠู† ุงู„ู€ DICุŸ
566
00:51:09,640 --> 00:51:13,380
ุจุงู„ุธุจุท ุงู„ู€ liver ุงู„ู„ูŠ ุจูŠุตู†ุน coagulation ููŠ ุงู„ู€ liver
567
00:51:13,380 --> 00:51:15,640
ุงู„ููŠุฒูŠุงู„ ูŠุนู†ูŠ ู…ุงููŠุด coagulation factors ู…ุงููŠุด
568
00:51:15,640 --> 00:51:20,680
coagulation ูˆู‚ุงู„ุช ู…ู† K deficiency ุชุฏูŠู†ุง ู†ูุณ ุงู„ุตูˆุฑุฉ
569
00:51:20,680 --> 00:51:27,040
liver disease TTP ูˆุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ุง ุฌู„ุทุงุช ู…ุชูƒุฑุฑุฉ
570
00:51:27,040 --> 00:51:32,080
ุซู… congenital abnormalities of fibrin and help
571
00:51:32,080 --> 00:51:37,290
syndrome ุงู„ู„ูŠ ู‡ูˆ hereditary elevated liver test
572
00:51:37,290 --> 00:51:43,690
with low platelet help ุงุฎุชุตุงุฑู†ุง ุฅูŠู‡ ูŠุง ุดุจุงุจ
573
00:51:43,690 --> 00:51:48,770
hereditary elevation
574
00:51:48,770 --> 00:51:58,130
of liver test with
575
00:51:58,130 --> 00:52:03,630
low platelet ุนู„ุงุฌ
576
00:52:03,630 --> 00:52:04,150
ุทุจุนุง
577
00:52:06,870 --> 00:52:10,930
ุฃูˆู„ ุดูŠุก stop the triggering factor ุทุจุนุง ุงู„ู€
578
00:52:10,930 --> 00:52:14,870
triggering factor ุจุฏูƒ ุชูˆู‚ูู‡ ููŠ ูƒุซูŠุฑ ู…ู† ุงู„ุฃุญูŠุงู†
579
00:52:14,870 --> 00:52:21,730
ุนู…ู„ูŠุฉ ุงู„ุชูˆู‚ูŠู ุชูƒูˆู† ุตุนุจุฉ ู…ุง ู„ู… ุชูƒู† ุฃู‚ูˆู‰ the only
580
00:52:21,730 --> 00:52:26,610
proof in the treatment ุฃู†ูƒ ุชูˆู‚ู ู…ูŠู† ุชุณุจุจ ุงู„ู€ VIC
581
00:52:26,610 --> 00:52:31,950
ุจุนุฏูŠู† ุชุฏูŠ support in the treatment ุทุจุนุง support in
582
00:52:31,950 --> 00:52:32,450
the treatment
583
00:52:38,010 --> 00:52:43,530
ู„ูŠุดุŸ ููŠ ุจุฏุงูŠุฉ ุงู„ู…ุฑุญู„ุฉุŸ ููŠ ุงู„ุจุฏุงูŠุฉ ุงู‡ ููŠ ุจุฏุงูŠุฉ ุงู„ู„ูŠ
584
00:52:43,530 --> 00:52:46,950
ุฏุงูƒู‡ ุงู‡ ู…ู…ูƒู† ุงู„ู€ non specific treatment is
585
00:52:46,950 --> 00:52:51,230
available ุญุณุจ ุงู„ู…ุฑุญู„ุฉ ุงู„ู„ูŠ ุฃู†ุง ุจู‚ูˆู„ู‡ ู…ู…ูƒู† ุชุนุทูŠ
586
00:52:51,230 --> 00:52:55,890
plasma ูˆ platelet substitution ู…ู…ูƒู† ุชุนุทูŠ
587
00:52:55,890 --> 00:53:00,050
anticoagulant ุฅุฐุง ูƒุงู† ููŠ ุงู„ุจุฏุงูŠุฉ ู…ู…ูƒู† ุชุนุทูŠ
588
00:53:00,050 --> 00:53:06,110
inhibitors ุฅุฐุง ูƒุงู† ููŠ ุงู„ุจุฏุงูŠุฉ ูˆูƒุฐุง ุทุจุนุง ู‡ุฐู‡ ุงู„ู€
589
00:53:06,110 --> 00:53:15,130
plasma therapy ู†ุฏูŠู‡ุง ูˆู‚ุชูŠุด ุฅุฐุง ููŠ bleeding ู…ุงุดูŠ
590
00:53:15,130 --> 00:53:19,710
fresh frozen plasma ุจุฑุถู‡ ุจุชุนุทู‰ ููŠ ุญุงู„ุงุช ู†ู‚ุต ุจุนุถ
591
00:53:19,710 --> 00:53:24,010
ุงู„ุนูˆุงู…ู„ platelet therapy ุฅุฐุง ุงู„ู€ platelet ูƒุงู†ุช ูˆุงุทูŠุฉ
592
00:53:24,010 --> 00:53:29,990
ู…ุงุดูŠ ูˆblood ุฅุฐุง ุตุงุฑ ุนู†ุฏ ุงู„ู…ุฑูŠุถ ุฃู†ูŠู…ูŠุง or disease
593
00:53:29,990 --> 00:53:34,840
destruction Coagulation InhibitorsุŒ Antithrombin 3
594
00:53:34,840 --> 00:53:37,240
ูˆ Protein C ูˆ Tissue Factor Pathway Inhibitor ูˆ
595
00:53:37,240 --> 00:53:43,080
Heparin ุทุจุนุง ู„ุฅู†ู‡ ุจูŠุณุชู‡ู„ูƒูˆุง ูƒู…ุงู† ุจูŠุนุทูˆู‡ ูˆู‡ุฐุง
596
00:53:43,080 --> 00:53:48,180
ุงู„ุนู„ุงุฌ ุฃู†ุง ู…ุด ุฑุงุญ ุฃุฎุฏ ููŠู‡ ุจุงู„ุชูุตูŠู„ Anti
597
00:53:48,180 --> 00:53:55,880
Fibrinolytic ุฒูŠ ู…ุง ู‚ุงู„ ุจุฑุถู‡ ุจุชุนุทู‰ ููŠ ุฏูŠ ุฏุงูŠุงุช ุงู„ุญุฏ
598
00:53:55,880 --> 00:53:59,200
ุงู„ู„ูŠ ู…ุด ุนุงุฑู ุงู„ุดุบู„ุŒ ุทูŠุจ no question ูŠุนู†ูŠุŸ